WO2001049196A9 - Thermal protection for methods of treating arthroscopic pathologies - Google Patents

Thermal protection for methods of treating arthroscopic pathologies

Info

Publication number
WO2001049196A9
WO2001049196A9 PCT/US2000/035313 US0035313W WO0149196A9 WO 2001049196 A9 WO2001049196 A9 WO 2001049196A9 US 0035313 W US0035313 W US 0035313W WO 0149196 A9 WO0149196 A9 WO 0149196A9
Authority
WO
WIPO (PCT)
Prior art keywords
thermal energy
cartilage
solution
temperature
probe
Prior art date
Application number
PCT/US2000/035313
Other languages
French (fr)
Other versions
WO2001049196A1 (en
Inventor
Mark Markel
Hugh R Sharkey
Gary S Fanton
Original Assignee
Oratec Interventions Inc
Mark Markel
Hugh R Sharkey
Gary S Fanton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oratec Interventions Inc, Mark Markel, Hugh R Sharkey, Gary S Fanton filed Critical Oratec Interventions Inc
Priority to AU22927/01A priority Critical patent/AU2292701A/en
Publication of WO2001049196A1 publication Critical patent/WO2001049196A1/en
Publication of WO2001049196A9 publication Critical patent/WO2001049196A9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320016Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/148Probes or electrodes therefor having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/1604Chisels; Rongeurs; Punches; Stamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3203Fluid jet cutting instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1442Probes having pivoting end effectors, e.g. forceps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320068Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic
    • A61B2017/320072Working tips with special features, e.g. extending parts
    • A61B2017/320078Tissue manipulating surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1246Generators therefor characterised by the output polarity
    • A61B2018/126Generators therefor characterised by the output polarity bipolar

Definitions

  • This invention relates generally to a method and apparatus for treating chondromalacia, and more particularly to a method and apparatus that treats chondromalacia with minimal disruption of the cartilage bed of the knee.
  • This invention also relates generally to thermal therapy techniques for treating joint pathologies arthroscopically. More specifically, techniques to manipulate the thermal dynamic aspects of the joint capsule environment as approached arthroscopically.
  • articular cartilage The normal function of joints in humans depends on the distribution of relatively large forces across the body surfaces. In diarthrodial joints the magnitude of the joint forces reaches levels four to seven times body weight. These forces applied to joints are dispersed by articular cartilage. Cartilage function occurs via a highly organized extracellular matrix maintaining a fixed charge density and possessing a high affinity for water. Normal articular cartilage consists of an assembly of large and small proteoglycans, collagens, hyaluronic acid and glycoproteins. These matrix macromolecules originate from chondrocytes localized in a nonrandom pattern through the cartilage matrix. In normal joints, chondrocytes do not proliferate; dividing chondrocytes indicate a change in cartilage homeostasis, either as regeneration or attempted repair.
  • Chondromalacia occurs when cartilage beds in joints become worn and strands of cartilage distended away from their respective cartilage beds and extend into the joint capsule.
  • the cartilage surface becomes visibly disrupted, fissured and fibriUated. This has deterious effects on the mechanical properties of articular cartilage. This distension has been associated with knee pain.
  • Treatment to date has included surgical intervention. In one arthroscopic procedure, a shaver is introduced through an arthroscope and is used to remove the strands of disrupted and fibriUated cartilage. However, this treatment can disrupt and remove part of the normal cartilage bed and does not restore a smooth surface nor the mechanical function.
  • Arthroscopic interventions include a variety of modalities in the treatment of various joint pathologies. These modalities include mechanical shavers, electrosurgical devices, mechanical burrs and drills and electrothermal interventions for the modification of collagenous structures. Heat may be generated by mechanical means as a byproduct of friction, or by ohmic (resistive) heating as a result of electromagnetic currents passing through tissues generating heat. In certain instances, thermal insult of the adjacent structures can have significant implications and must be minimized to the maximum extent possible. The inadvertent exposure to these adjacent tissues can result in the loss of important viable cells not intended for destruction, such as articular cartilage, subchondral bone and neurovascular structures that may reside in close proximity to structures intended for these therapies. One such instance is in the treatment of chondromalacia by electrothermal coagulation of the fibriUated cartilage surface.
  • Chondromalacia is a condition of the articular cartilage, particularly the knee that is addressed using thermal techniques.
  • Conventional treatment for chondromalacia involves debridement by mechanically cutting or shaving of any non- viable or troublesome tissues at the time of arthroscopic surgery. This condition has also been approached with lasers and conventional electrosurgery devices.
  • Thermal chondroplasty utilizing a temperature feedback system has several advantages over the mechanical shaving method. With debridement and mechanical shaving, inadvertent disruption of healthy viable articular cartilage is practically unavoidable and further results in dysfunction of the joint. Further, the resultant surface architecture of the haline cartilage remains discarded whereby remaining articular cartilage strands are still present in the joint area and bits of fibriUated cartilage continue to serve as a source of joint inflammation and pain.
  • the thermal treatment approach provides both a smooth gliding surface for the corresponding arcticular surfaces and coagulates and seals the fibriUated strands.
  • the fibriUated strands would otherwise break off as a result of further degeneration and mechanical wear due to the pressure of weight bearing and movement during joint articulation.
  • These remnants of cartilage irritate the joint, in particular the synovial lining, which became inflamed from contact with these free floating pieces of tissue and the chemical components that are a byproduct of the breakdown of these tissues.
  • Such an approach should be able to treat targeted cartilage surfaces and other structures found in the arthroscopic setting in conjunction with thermal therapy procedures, and to simultaneously protect healthy and viable non-targeted tissues that are in close proximity to, or are continuous with, tissues targeted for thermal treatment.
  • Such an approach should allow, for example, the treatment of damaged articular cartilage with minimal or no injury to the underlying viable cartilage and subchondral bone or other structures in the diarthrodial joint.
  • an object of the invention is to provide a method and apparatus for treating fibriUated or irregular cartilage joint surfaces.
  • Another object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to reduce a level of fibrillation of a fibriUated cartilage joint surface.
  • Yet another object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to modify a fibriUated cartilage joint surface to a smooth surface.
  • a further object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to modify an irregular cartilage joint surface to a smoother surface.
  • Still a further object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to at least a portion of a plurality of cartilage strands coupled to a fibriUated cartilage surface, and melt the strands onto the fibriUated cartilage surface.
  • Another object of the invention is to provide a method and apparatus that uses thermal energy to treat chondromalacia.
  • a thermal energy delivery apparatus that has a probe means including a distal end and a proximal end.
  • a first electrode means is positioned at the distal end of the probe means.
  • the first electrode means is configured to deliver sufficient thermal energy to a fibriUated cartilage surface to reduce a level of fibrillation of the fibriUated cartilage surface.
  • a cabling means is coupled to the proximal end of the probe means.
  • an apparatus is configured to be positioned adjacent to a fibriUated cartilage joint surface.
  • a probe means has a distal end and a proximal end.
  • An insulator means has a first surface and a second surface.
  • a first electrode means is positioned on the first surface of the insulator.
  • the first electrode means has a first thermal energy delivery surface configured to deliver sufficient thermal energy to a plurality of cartilage strands coupled to the fibriUated cartilage joint surface to reduce a level of fibrillation of surface.
  • a second electrode means is positioned on the second surface of the insulator.
  • a cable means is coupled to the proximal end of the probe means.
  • a method modifies a geometry of a fibriUated cartilage surface.
  • a thermal energy delivery device is provided and includes a probe means with a distal end and a thermal energy delivery surface.
  • a thermal energy source is also provided and coupled to the thermal energy delivery surface.
  • the thermal energy delivery surface is positioned adjacent to the fibriUated cartilage surface in a non-contacting position. Sufficient thermal energy is delivered from the thermal energy delivery surface to reduce a level of fibrillation of the fibriUated cartilage surface.
  • the method and apparatus of the present invention can also be used to decrease the level of irregularity of an irregular cartilage surface.
  • the apparatus of the present invention may also include a sensor means positioned at the distal end of the probe means.
  • a comparator means is provided and compares a measured temperature value at the sensor means with a predetermined temperature value.
  • the comparator means generates a disabling signal if the measured temperature value exceeds the predetermined maximum temperature value.
  • a communication means is provided and communicates the disabling signal to the thermal energy source means to cease further delivery of energy from the thermal energy source means to the first electrode means.
  • sufficient thermal energy is delivered from the thermal energy delivery surface to modify the fibriUated cartilage surface to a smooth surface. Thermal energy is delivered from the thermal energy delivery surface to create a less fibriUated, fibriUated cartilage surface.
  • Thermal energy is delivered from the thermal energy delivery surface to cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to create a smoothened cartilage surface.
  • Thermal energy is delivered from the thermal energy delivery surface to cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to melt onto the fibriUated cartilage surface. At least a portion of a plurality of cartilage strands are melted to create a smoothened cartilage surface.
  • a method according the invention includes the pre-cooling of tissue by means of an irrigating solution cooled to a very low temperature.
  • the cooled solution is used to Lavage the joint for a period of time prior to the application of thermal therapeutic energy. It will be appreciated that such low temperatures decrease the temperature of the associated structures exposed within the field of the synovial cavity, thus providing a conventive thermal offset that will limit any temperature rise in response to any thermal energy applied to the tissue.
  • the presence of the lower offset temperature protects the non-targeted tissue from collateral damage as a result of the thermal treatment.
  • Figure 1 is a perspective view of the apparatus of the present invention with a probe and two electrodes.
  • Figure 2 is a perspective view of the apparatus of the present invention with a probe, an electrode positioned at a distal end of the probe and two electrodes positioned on opposite sides of an insulator.
  • Figure 3 is a perspective view of a knee joint with chondromalacia.
  • Figure 4 is a perspective view of the apparatus of Figure 2 with a probe coiled distal end.
  • Figure 5 is a perspective view of the apparatus of the present invention with two electrodes positioned on opposite sides of an insulator.
  • Figure 6 is perspective view of the apparatus of the present invention including an electrode with radiused edges.
  • Figure 7 is a perspective view of the apparatus of the present invention including a rectangularly shaped electrode.
  • Figure 8 illustrates a perspective view of the apparatus of the present invention with electrodes formed on peripheral faces of the insulator.
  • Figure 9 is a cross-sectional view of the apparatus of Figure 8 taken along the lines 9-9.
  • Figure 10 is a perspective view of an electrode used with the apparatus of the present invention that is formed at a peripheral surface of the insulator and defines an interior non-conducting region.
  • Figure 11 is a perspective view of a toroidal electrode used with the apparatus of the present invention and defines an interior non-conducting region.
  • Figure 12 is a perspective view of a non-circular toroidal electrode used with the apparatus, of the present invention and defines an interior nonconducting region.
  • Figure 13 is a perspective view of a segmented electrode used with the apparatus of the present invention.
  • Figure 14 is a perspective view of a segmented toroidal electrode used with the apparatus of the present invention.
  • Figure 15 is a perspective view of a flexible probe used with the apparatus of the present invention.
  • Figure 16 is a block diagram illustrating a feedback system useful to control the temperature of electrodes of the present invention.
  • Figure 17 illustrates a circuit useful to implement the feedback system of Figure 16.
  • Figs. 18A-18B illustrate two views of results obtained at 10°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
  • Figs. 19A-19B illustrate two views of results obtained at 15°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
  • Figs. 20A-20B illustrate two views of results obtained at 5°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
  • Figs. 21 A-21B illustrate two views of results obtained at 15°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
  • Figs. 22A-22B illustrate two views of results obtained at 22°C Lavage, 20 watts and a 60°C probe temperature, representing an embodiment of the invention.
  • Figs. 23A-23B illustrate two views of results obtained at 37°C Lavage, 20 watts and a 60°C probe temperature, representing an embodiment of the invention.
  • a thermal energy delivery apparatus 10 is configured to be positioned adjacent to, but spaced apart from a joint surface. Included is a probe 12 with a distal end 14, a first electrode 22 and a second electrode 24. Electrodes 22 and 24 can be operated in bipolar or monopolar. Bipolar is preferred. A distancing element 25 distances a thermal energy delivery surface of electrode 22 from the joint surface. Preferably, the thermal energy delivery surface of electrode 22, or of electrode 24, does not touch the joint surface. As illustrated in Figure 1, distancing element 25 is included. In other embodiments, distancing element 25 is not included and the thermal energy delivery surface of electrode 22 or of electrode 24 are positioned directly on the joint surface.
  • thermal energy delivery apparatus 10 is configured to be positioned and deliver thermal energy to a joint surface.
  • Apparatus 10 includes probe 12 with distal end 14 and an insulator 16 including first and second surfaces 18 and 20 formed on opposite sides on insulator 16. A pair of electrodes are also provided.
  • First electrode 22 is positioned on first surface 18 of insulator 16.
  • Second electrode 24 is positioned on second surface 20 of insulator 16.
  • Thermal energy source 26 is coupled to first electrode 22 and second electrode 24 with a cable.
  • Insulator 16 can be an elongated structure with a longitudinal axis. Surfaces 18 and 20 can be parallel to each other. Insulator can be made of a variety of insulating materials known to those skilled in the art. Insulator 16 need not be one integral unit and surfaces 18 and 20 can be made of separate insulators that are separated. Surfaces 18 and 20 can be planar, non-planar and have geometries that conform closely to interior joint surfaces. In one embodiment, the dimensions of distal end 14 are sufficiently small to be positioned on a joint surface.
  • Knee joint surface 28 is defined by a first cartilage bed 30 formed at a distal end of the femur, and a second cartilage bed 32 formed at a distal end of the tibia.
  • the present invention is not limited to the knee joint surface and can be used in a variety of different joint surfaces. Any joint surface susceptible to chondromalacia is treatable with apparatus 10.
  • the present invention is suitable for the treatment of fibriUated cartilage joint surfaces to reduce the level of fibrillation and create smoother surfaces.
  • the present invention is also used to treat irregular joint surfaces, where there are peaks and valleys, and create a less irregular joint surface. In certain embodiments, the irregular joint surface becomes a smooth joint surface.
  • a first plurality of cartilage strands 34 are coupled to first cartilage bed 30 and have become dislodged and dangle in joint surface 28.
  • a second plurality of cartilage strands 36 are connected to second cartilage bed 32. Second plurality of cartilage strands 36 have also become dislodged and dangle in joint surface 28.
  • a method modifies a geometry of a fibriUated cartilage surface.
  • Sufficient thermal energy is delivered from first electrode 22 or second electrode 24 at different times to reduce a level of fibrillation of the fibriUated cartilage joint surface.
  • sufficient thermal energy is delivered electrode 22 or 24 to, (i) change the fibriUated cartilage surface to a smooth or smoother surface, (ii) reduce a level of fibrillation of the fibriUated cartilage surface, (iii) cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to create a smoothened cartilage surface, (iv) cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to melt onto the fibriUated cartilage surface or (v) melt at least a portion of a plurality of cartilage strands to create a smoothened cartilage surface.
  • First electrode 22 has a first thermal energy delivery surface configured to deliver thermal energy to cartilage strands 34 and second electrode 24 has a second thermal energy delivery surface configured to deliver thermal energy to cartilage strands 36.
  • Thermal energy includes but is not limited to RF, microwave, resistive heating, ultrasound, coherent or incoherent light and a thermal jet source.
  • Apparatus 10 is used to modify the geometry of cartilage strands 34 and 36 through cartilage shrinkage and possibly limited ablation of strands 34 and 36.
  • Distal end 14 of probe 12 is inserted through an arthroscope to joint surface 28.
  • First and second electrodes 22 and 24 are introduced into joint surface 28.
  • Sufficient thermal energy is delivered from electrodes 22 and 24 to shrink at least a portion of cartilage strands 34 and 36, causing the strands to lie down on cartilage beds 30 and 32.
  • the delivery of thermal energy to joint surface 28 results in an "ironing" of cartilage strands 34 and 36 onto cartilage beds 30 and 32.
  • Sufficient thermal energy is delivered from first and- second electrodes 22 and 24 to shrink at least a portion of cartilage strands 34 and 36 without ablating more than 25% of cartilage beds 30 and 32.
  • sufficient energy is delivered by first and second electrodes 22 and 24 to raise the temperature of joint surface in the range of 45 to 90 degrees C, preferably 45 to 75 degrees C and more preferably 50 to 70 degrees C.
  • Maintenance of a suitable temperature, and the delivery of thermal energy to joint surface 28 is sufficient to cause strands 34 and 36 to become at least partially melted onto the cartilage joint surface while minimizing ablation of cartilage beds 30 and 32.
  • Insulator 26 and first and second electrodes 22 and 24 are configured to be inserted into joint surface 28.
  • Probe 12 is moved back and forth through joint surface 28 to deliver a sufficient amount of thermal energy to strands 34 and 36 to cause them to lie down on their respective cartilage beds.
  • the thermal energy delivery surfaces of first and second electrodes 22 and 24 can move along the surfaces of cartilage beds 30 and 32 to complete the ironing effect.
  • distal end 14 of probe 12 can have a coiled geometry as well as a variety of geometric configurations.
  • distal end 14 is malleable or sufficiently flexible to impart movement of first and second electrodes 22 and 24.
  • Distal end 14 can pivot, be hinged, be articulated, or made of a shaped memory metal, and the like, in order to enable first and second electrodes 22 and 24 to follow the contours of joint surface 28.
  • first and second electrodes 22 and 24 can be operated in a bipolar mode. This concentrates the flow of RF energy between first and second electrodes 22 and 24 and diverts direct RF energy flow away from cartilage beds 30 and 32. RF energy which is directed between first and second electrodes 22 and 24 heats up fluids within joint surface 28 and provides a more controlled delivery of energy to cartilage strands 34 and 36. RF ablation of cartilage beds 30 and 32 is reduced.
  • First and second electrodes 22 and 24 can have a variety of different geometric configurations. As illustrated in Figure 6, first and second electrodes 22 and 24 are symmetrically shaped with radiused edges. Elimination of sharp edges at an electrode surface reduce the creation of hot spots of thermal energy delivered to a site.
  • first and second electrodes 22 and 24 have rectangular geometries with non-radiused edges. First and second electrodes 22 and 24 can each have different sizes and geometries. First and second electrodes 22 and 24 can be mirror images of each other or they can be different.
  • first and second electrodes 22 and 24 are formed on a periphery of insulation surfaces 18 and 20 respectively.
  • each electrode 22 and 24 defines a first and a second nonconducting region 38 and 40 on an insulator surface 18 and 20 within an interior of first and second electrodes 18 and 20.
  • Non-conducting regions 38 and 40 can be the actual surface of insulator 16, or may be additional structures, each with a non-conducting surface, that are formed on insulation surfaces 18 and 20.
  • First and second sensors 42 and 44 can be provided and associated with first and second electrodes 22 and 24 to measure temperature and/or impedance. First and second sensors 42 and 44 are positioned on a surface of first and second electrodes 22 and 24, on a surface of probe 12, on non-conducting regions 38 and 40, or can be advanced and retracted from distal end 14 to and from joint surface 28.
  • First and second sensors 42 and 44 are of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like.
  • Suitable thermal sensors 42 and 44 include a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like. Sensors 42 and 44 need not be thermal sensors.
  • Sensors 43 and; 44 measure temperature and/or impedance to permit monitoring and a desired level of energy delivered determined This reduces ablation damage to cartilage beds 30 and 32. If at any time sensor 42 or 44 determines that a desired temperature is exceeded, then an appropriate feedback signal is received at thermal energy source 26 which then regulates the amount of energy delivered to first and second electrodes 22 and 24.
  • Non-conducting regions 38 and 40 have a variety of geometric surfaces including but not limited to planar, non-planar, concave, convex, and the like. In one embodiment, non-conducting regions 38 and 40 are closer to the midline of insulator 16 than first and second electrodes 22 and 24. This enhances the bipolar conduction of thermal energy between electrodes 22 and 24 in the bipolar mode of operation.
  • First and second electrodes 22 and 24 can have various geometries including but not limited to cylindrical, semi-cylindrical, rectangular, cubic, irregularly shaped, toroidal (Figure 10), non-circular toroidal (Figure 11), non- symmetrical, non-symmetrical toroidal ( Figure 12) or be segmented and capable of multiplexing ( Figures 13 and 14).
  • first electrode 22 has a toroidal geometry
  • first sensor 42 is positioned on non-conducting region 38
  • distal end 14 is flexible and curved.
  • Figure 16 illustrates a block diagram of a temperature/impedance feedback system useful with apparatus 10.
  • Thermal energy is delivered to first and second electrodes 22 and 24 by thermal energy source 26, and applied to cartilage strands 34 and 36.
  • a monitor 56 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value a disabling signal 48 is transmitted to thermal energy source 26, ceasing further delivery of thermal energy to first and second electrodes 22 and 24. If measured impedance is within acceptable limits, energy continues to be applied.
  • sensor 42 measures the temperature at the surface of sensor 42.
  • a comparator 50 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. Comparator 50 sends a signal to thermal energy source 26 to continue sending thermal energy, to increase or decrease the level of delivered thermal energy, or to cease delivery of thermal energy.
  • An output 52 from temperature comparator 50 can be input to thermal energy source 26 to regulate the amount of power delivered.
  • Output 54 from impedance monitor 56 can be input control the temperature at joint surface 28.
  • thermal energy source 26 is coupled to first and second electrodes 22 and 24 and apply a biologically safe voltage to cartilage strands 34 and 36.
  • apparatus 10 is represented as a bipolar ablation device.
  • First and second electrodes 22 and 24 are connected to a primary side of transformer windings 58 and 60.
  • the common primary windings 58 and 60 are magnetically coupled with a transformer core to secondary windings 58' and 60'.
  • the primary windings 58 of the first transformer t couple the output voltage of apparatus 10 to the secondary windings 58'.
  • the primary windings 60 of the second transformer t 2 couple the output current of ablation apparatus 10 to the secondary windings 60'.
  • Measuring circuits determine the root mean square (RMS) values or magnitudes of the current and voltage. These values, represented as voltages, are inputted to a diving circuit D to geometrically calculate, by dividing the RMS voltage value by the RMS current value, the impedance of the tissue site at sensor 42.
  • RMS root mean square
  • the output voltage of the divider circuit D is presented at the positive (+) input terminal of comparator A.
  • a voltage source V 0 supplies a voltage across the variable resistor R ⁇ thus allowing one to manually adjust the voltage presented at the negative input of comparator A.
  • This voltage represents a maximum impedance value beyond which power will not be applied to electrode 22.
  • thermal energy source 26 stops supplying energy to first and second electrodes 22 and 24.
  • Comparator A can be of any of a commercially available type that is able to control the amplitude or pulse width modulation of thermal energy source 26.
  • the temperature within joint surface 28 can be controlled based on the tissue impedance, as represented by signal 62, or based on tissue temperature, as represented by signal 64.
  • the switch S is activated to allow the impedance signal 62 to enter the positive (+) input terminal of comparator A. This signal along with the reference voltage applied to the negative (-) input terminal actuates comparator A to produce an output signal. If the selected tissue ablation site is heated to a biologically damaging temperature, the tissue impedance will exceed a selected impedance value seen at the negative (-) input terminal, thereby generating disabling signal 48 to disable thermal energy source 26, ceasing the energy supplied to first and second electrodes 22 and 24.
  • the output signal of comparator A may either disable thermal energy source's 26 energy output, depending on the tissue temperature as reflected by its impedance.
  • the thermal energy source 26 of apparatus 10 may also be used in combination with pre-cooling system 70 comprising a coolant source and a pump.
  • the pre-cooling system 70 can be used to Lavage the joint with an irrigating solution which has been placed into a freezer or refrigerator to be chilled at or below 0°C before use in the surgical procedure.
  • the irrigating solution lowers the joint surface and target tissue temperature for treatment below the typical body temperature of 37°C.
  • Temperature sensor 46 is used to monitor the temperature of the tissue in the surgical field.
  • the pre-cooled thermal environment provides protection from collateral damage to non-targeted tissue.
  • thermal energy is applied from RF generator 34 to the primary winding 58 in the electrode of the apparatus, a thermal gradient is formed as the apparatus is placed near the joint surface for treatment.
  • the thermal energy heats the joint surface and target tissue for a pre-determined amount of time to produce a desired ablation effect on the cartilage strands of the joint surface to smooth the surface during treatment.
  • the targeted tissue strands are heated and ablated with reduced thermal effect on the underlying non-targeted joint surface.
  • the chondrocytes in the articular cartilage surface remain viable and are minimally affected by the thermal energy from the apparatus during a surgical procedure.
  • FIGS. 18A-23B illustrate the in vitro studies of apparatus 10 utilizing a pre-cooling system 70 as shown in FIG. 17. All of the treated tissues shown in FIGS. 18A-23B were treated to substantially the same level of smoothness. All of the images shown in FIGS. 18A-23B at depicted at substantially the same magnification.
  • the term approximately, as used herein, is defined as at least close to a given value (e.g., preferably within 10% of, more preferably within 1% of, and most preferably within 0.1% of).
  • the term substantially, as used herein, is defined as at least approaching a given state (e.g., preferably within 10% of, more preferably within 1% of, and most preferably within 0.1% of).
  • the term coupled, as used herein, is defined as connected, although not necessarily directly, and not necessarily mechanically.
  • FIGS. 18A-B illustrate a treatment with an irrigating solution at a temperature of approximately 10°C.
  • FIG. 18A is a color microscopic cross-section of the articular cartilage surface 100 after pre-cooling treatment while FIG. 18B is a black and white representation for reference.
  • the probe velocity was 1 mm/sec and applied with a motorized apparatus. Cell death is indicated by red with some staining artifacts remaining.
  • the irrigating solution was cooled to 10°C under 40W of power and a probe temperature of 80°C.
  • the underlying articular cartilage bed 101 shows minimal cell death after thermal energy application along tissue surface 100 during treatment wherein viable chondrocytes are unaffected by the probe apparatus.
  • FIGS. 19A-B illustrate a treatment with an irrigating solution at a temperature of approximately 15 °C.
  • FIG 19A is a color microscopic cross-section of the articular cartilage surface 110 after pre-cooling treatment while FIG. 19B is a black and white representation for reference.
  • the probe velocity was 1 mm/sec and applied with a motorized apparatus.
  • the irrigating solution was cooled to 15°C under 40W of power and a probe temperature of 80°C.
  • the underlying articular cartilage bed 111 shows minimal cell death along treated cartilage surface 100.
  • FIGS. 20A-B illustrate a treatment with an irrigating solution at a temperature of approximately 5 °C.
  • FIG. 20A is a color microscopic cross-section of the articular cartilage surface 120 after pre-cooling treatment while FIG. 20B is a black and white representation for reference.
  • the probe velocity was 1 mm/sec and applied with a motorized apparatus.
  • the irrigating solution was cooled to 5°C under 40 W of power and a probe temperature of 80°C.
  • the underlying articular cartilage bed 121 shows minimal cell death along treated cartilage surface 120.
  • FIGS. 21 A-B illustrate a treatment with an irrigating solution at a temperature of approximately 15 °C.
  • FIG.21 A is a color microscopic cross-section of the articular cartilage surface 200 after pre-cooling treatment while FIG. 21B is a black and white representation for reference.
  • Hand pressure was used on the probe apparatus to test if physical insult and pressure in addition to the application of thermal energy to the target joint surface tissue would result in greater cell death to non-targeted tissue.
  • the irrigating solution was cooled to 15°C under 40W of power with a probe temperature of 80°C.
  • the non-targeted tissue 201 beyond where the physical pressure was applied to the articular cartilage illustrates protection from the thermal effect of the probe.
  • FIGS. 22A-B illustrate a treatment with an irrigating solution at a room temperature of approximately 22 °C.
  • FIG.22A is a color microscopic cross-section of the articular cartilage surface 210 while FIG. 22B is a black and white representation for reference.
  • Power was reduced to 20W while the probe temperature was reduced to 60°C.
  • the probe velocity was Imm/sec and applied with a motorized apparatus. As the thermal energy was applied to the joint surface tissue 210, cell death occurred at both the treated surface 210 and below the tissue surface in area 215 of the articular cartilage 211 beyond the treatment area of articular cartilage surface 210.
  • FIGS. 23 A-B illustrate a treatment with an irrigating solution at a body temperature of approximately 37°C.
  • FIG.23 A is a color microscopic cross-section of the articular cartilage surface 220 while FIG. 23 B is a black and white representation for reference.
  • Power was reduced to 20W while the probe temperature was reduced to 60°C.
  • the probe velocity was lmm/sec and applied with a motorized apparatus.
  • significant cell death occurred along the tissue surface 220 and beyond and below the treatment area of articular cartilage surface 220 over a greater area 225 of the articular cartilage 221 as shown by the red stain.
  • a larger tissue cartilage depth and lower probe temperature and power showed a greater effect and cell death from thermal insult than pre-cooled tissues at higher probe temperatures and powers as shown in FIGS. 18-21.
  • the arthroscopic set up includes an irrigating system, a viewing system and a positioning system in addition to the normal equipment utilized in a less invasive procedure conducted under general anesthesia.
  • the irrigating system involves a fluid (irrigant) source (typically two liter bags of normal or isotonic saline), connecting tubing to include tubing clamps for mechanically inhibiting and controlling the flow of the irrigating solution, the percutaneous canula for insertion into the joint space to which the connecting tubing is attached providing the portal for irrigant supply, and a second portal or outflow port allowing irrigating fluid to exit the joint capsule which may have an extension tube to direct the outflow of the irrigant away from the operator.
  • the irrigating solutions are commonly stored in the operating room and are then used at (room) stored temperature.
  • Either (or both) of these canulas may be incorporated into a canula system allowing the introduction of a "scope" (rod lens apparatus for viewing the interior of the joint space) or the introduction of all manner of interventional tools, to include probe cutters, electrosurgical and electrothermal instruments.
  • a "scope" rod lens apparatus for viewing the interior of the joint space
  • interventional tools to include probe cutters, electrosurgical and electrothermal instruments.
  • Some surgeons utilize a pump system that senses intra-articular pressure and adequate hemostasis. Otherwise, the intra-articular (joint capsule) pressure is generated by elevating the solution bags above the level of the patient making use of a simple gravity supply.
  • the viewing system includes the arthroscopic "scope” (optical rod lens) to which is typically attached a clip on video camera that feeds a video signal to the camera base and a CRT monitor for viewing.
  • arthroscopic "scope” optical rod lens
  • a positioning system is selected, based upon the anatomy to be addressed with each procedure that is designed to immobilize or suspend the surgical site to facilitate the physician's access to the surgical field.
  • a preferred embodiment utilizes the standard arthroscopic system with the following modifications.
  • the irrigating solution can cooled significantly by placing the solutions in a freezer or refrigerator. Because Normal Saline and Lactated Ringers Solution contain salts and sugars in solution they can be chilled to temperatures at or below 0°C without the concern of the solution freezing or forming crystals.
  • the invention can include the use of a subsystem including an irrigating solution reservoir coupled to a heat exchanger.
  • the solution in the reservoir can thus be delivered to the non-targeted tissue at any temperature at any time, during even a lengthy procedure.
  • the invention can also utilize data processing methods that transform signals from solution to control the temperature of the solution.
  • the invention can be combined with instrumentation to obtain state variable information to actuate interconnected discrete hardware elements.
  • the operation of the reservoir heat exchanger subsystem can be controlled by the use of one, or more, set point(s) in conjuction with an algorithm.
  • the algorithm can gather state variable data such as a deviation of the temperature of the irrigating solution in the reservoir from the set point(s) and dynamic data such as the rate of change of the temperature of the irrigating solution in the reservoir.
  • the algorithm can transform the set point(s), the state variable data and/or the dynamic data the into control signals that actuate the heat exchanger to control the temperature of the solution (e.g., start a pump in the heat exchanger to lower the temperature of the solution in the reservoir).
  • the invention can also be included in a kit.
  • the kit can include some, or all, of the components that compose the invention. More specifically, the kit can include the probe, conduits for providing the solution to the non-targeted tissue and other components of the invention. The kit can also include the solution.
  • the kit can also contain instructions for practicing the invention and apparatus for carrying out the invention. Unless otherwise specified, the components (and apparatus and/or instructions) of the kit can be the same as those used in the invention.
  • the cooled solution is used to "Lavage" the joint capsule for several minutes during the initial visual examination upon entering the joint before performing an intervention that will utilize a thermal device. Temperature of the solution exiting the outflow port can be monitored to assess the superficial intra-articular temperature by comparing the temperature of the in-flow irrigant with the temperature of the out-flow irrigant at low flow rates. In this way, the temperature of the tissues in the joint capsule and the tissues up to a centimeter away from the joint capsule can be cooled significantly.
  • Cooling the tissues in this way sets up a thermal gradient that offsets the thermal influence of the intervention.
  • Both targeted and non-targeted tissues are cooled requiring an adjustment of the thermal probe accordingly and allowing for the use of higher temperatures spread away from the target area.
  • the goal is to prevent temperature elevations in non-targeted tissues from exceeding 44°C. above which cell death occurs.
  • the normal warming effects of vascularized tissue can be negated when the tourniquet is employed and greater cooling can be achieved that persists for a longer period of time. There are no untoward effects of cooling these ligamentous and bony structures to near freezing temperatures for a limited period of time.
  • the invention provides for the virtual elimination of thermal insult when compared to approaches that take no thermal defensive measures.
  • the invention has the added benefit of greater heamostasis control even when a tourniquet is employed and even in the face of higher patient blood pressure.

Abstract

An apparatus (10) to protect non-targeted tissues in an arthroscopic environment comprising a thermal energy delivery device including a probe (12) with a distal end (14) and a proximal end and a thermal energy delivery surface. A thermal energy source (26) is coupled to the thermal energy delivery surface. A conduit provides a cooling irrigating solution to the arthroscopic environment. A similar kit is provided.

Description

THERMAL PROTECTIONFOR METHODS OFTREATING ARTHROSCOPICPATHOLOGIES
BACKGROUND OF THE INVENTION Field of the Invention
This invention relates generally to a method and apparatus for treating chondromalacia, and more particularly to a method and apparatus that treats chondromalacia with minimal disruption of the cartilage bed of the knee.
This invention also relates generally to thermal therapy techniques for treating joint pathologies arthroscopically. More specifically, techniques to manipulate the thermal dynamic aspects of the joint capsule environment as approached arthroscopically.
Description of Related Art
The normal function of joints in humans depends on the distribution of relatively large forces across the body surfaces. In diarthrodial joints the magnitude of the joint forces reaches levels four to seven times body weight. These forces applied to joints are dispersed by articular cartilage. Cartilage function occurs via a highly organized extracellular matrix maintaining a fixed charge density and possessing a high affinity for water. Normal articular cartilage consists of an assembly of large and small proteoglycans, collagens, hyaluronic acid and glycoproteins. These matrix macromolecules originate from chondrocytes localized in a nonrandom pattern through the cartilage matrix. In normal joints, chondrocytes do not proliferate; dividing chondrocytes indicate a change in cartilage homeostasis, either as regeneration or attempted repair.
Chondromalacia occurs when cartilage beds in joints become worn and strands of cartilage distended away from their respective cartilage beds and extend into the joint capsule. The cartilage surface becomes visibly disrupted, fissured and fibriUated. This has deterious effects on the mechanical properties of articular cartilage. This distension has been associated with knee pain. Treatment to date has included surgical intervention. In one arthroscopic procedure, a shaver is introduced through an arthroscope and is used to remove the strands of disrupted and fibriUated cartilage. However, this treatment can disrupt and remove part of the normal cartilage bed and does not restore a smooth surface nor the mechanical function.
It would be desirable to provide a method and apparatus treating fibriUated cartilage joint surfaces or irregular cartilage joint surfaces by delivering sufficient thermal energy to reduce a level of fibrillation or irregularity of the fibriUated cartilage joint surface or the irregular cartilage joint surface. It would also be desirable to modify the fibriUated cartilage surface to a smooth surface. It would be further desirable to treat chondromalacia by reducing a level of fibrillation or irregularity of a fibriUated or irregular cartilage joint surface.
Arthroscopic interventions include a variety of modalities in the treatment of various joint pathologies. These modalities include mechanical shavers, electrosurgical devices, mechanical burrs and drills and electrothermal interventions for the modification of collagenous structures. Heat may be generated by mechanical means as a byproduct of friction, or by ohmic (resistive) heating as a result of electromagnetic currents passing through tissues generating heat. In certain instances, thermal insult of the adjacent structures can have significant implications and must be minimized to the maximum extent possible. The inadvertent exposure to these adjacent tissues can result in the loss of important viable cells not intended for destruction, such as articular cartilage, subchondral bone and neurovascular structures that may reside in close proximity to structures intended for these therapies. One such instance is in the treatment of chondromalacia by electrothermal coagulation of the fibriUated cartilage surface.
Chondromalacia is a condition of the articular cartilage, particularly the knee that is addressed using thermal techniques. Conventional treatment for chondromalacia involves debridement by mechanically cutting or shaving of any non- viable or troublesome tissues at the time of arthroscopic surgery. This condition has also been approached with lasers and conventional electrosurgery devices.
One apparatus and method as described in parent application U.S. Ser. No. 08/700,196, filed August 20, 1996, now pending, describes treating the fibriUated cartilage surfaces by utilizing the properties of the collage component of the articular cartilage. These properties allow the doctor to treat chondromalacia or other chondral defects with thermal energy at levels that coagulate the fibriUated or non-intact cartilage tissue, sealing the articular cartilage structures thereof, thereby inhibiting further degradation of the cartilage matrix. The mechanical aspects of the knee joint are thus maintained with little change in articular function.
Thermal chondroplasty utilizing a temperature feedback system has several advantages over the mechanical shaving method. With debridement and mechanical shaving, inadvertent disruption of healthy viable articular cartilage is practically unavoidable and further results in dysfunction of the joint. Further, the resultant surface architecture of the haline cartilage remains discarded whereby remaining articular cartilage strands are still present in the joint area and bits of fibriUated cartilage continue to serve as a source of joint inflammation and pain.
The thermal treatment approach provides both a smooth gliding surface for the corresponding arcticular surfaces and coagulates and seals the fibriUated strands. The fibriUated strands would otherwise break off as a result of further degeneration and mechanical wear due to the pressure of weight bearing and movement during joint articulation. These remnants of cartilage irritate the joint, in particular the synovial lining, which became inflamed from contact with these free floating pieces of tissue and the chemical components that are a byproduct of the breakdown of these tissues.
Concerns related to the use of thermal energy in close proximity to healthy and viable tissues (i.e., non-targeted tissues) include the potential for thermal collateral damage or injury to tissues not intended for removal or treatment. The thermal effect on non-targeted tissues is compounded by the articular cartilage natural characteristic of not having the ability to repair itself or regenerate as with other types of tissue. Thus, temperature feedback control devices and methods limit, but do not all together eliminate these potential adverse effects.
For these reasons, it would be desirable to provide an approach to reducing this type of collateral damage and further limit and reduce the potential for extraneous and collateral thermal exposure of non-targeted tissue. Such an approach should be able to treat targeted cartilage surfaces and other structures found in the arthroscopic setting in conjunction with thermal therapy procedures, and to simultaneously protect healthy and viable non-targeted tissues that are in close proximity to, or are continuous with, tissues targeted for thermal treatment. Such an approach should allow, for example, the treatment of damaged articular cartilage with minimal or no injury to the underlying viable cartilage and subchondral bone or other structures in the diarthrodial joint.
SUMMARY OF THE INVENTION
Accordingly, an object of the invention is to provide a method and apparatus for treating fibriUated or irregular cartilage joint surfaces.
Another object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to reduce a level of fibrillation of a fibriUated cartilage joint surface.
Yet another object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to modify a fibriUated cartilage joint surface to a smooth surface.
A further object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to modify an irregular cartilage joint surface to a smoother surface.
Still a further object of the invention is to provide a method and apparatus for delivering sufficient thermal energy to at least a portion of a plurality of cartilage strands coupled to a fibriUated cartilage surface, and melt the strands onto the fibriUated cartilage surface.
Another object of the invention is to provide a method and apparatus that uses thermal energy to treat chondromalacia.
These and other objects of the invention are achieved in a thermal energy delivery apparatus that has a probe means including a distal end and a proximal end. A first electrode means is positioned at the distal end of the probe means. The first electrode means is configured to deliver sufficient thermal energy to a fibriUated cartilage surface to reduce a level of fibrillation of the fibriUated cartilage surface. A cabling means is coupled to the proximal end of the probe means. In one embodiment of the invention, an apparatus is configured to be positioned adjacent to a fibriUated cartilage joint surface. A probe means has a distal end and a proximal end. An insulator means has a first surface and a second surface. A first electrode means is positioned on the first surface of the insulator. The first electrode means has a first thermal energy delivery surface configured to deliver sufficient thermal energy to a plurality of cartilage strands coupled to the fibriUated cartilage joint surface to reduce a level of fibrillation of surface. A second electrode means is positioned on the second surface of the insulator. A cable means is coupled to the proximal end of the probe means.
In another embodiment, a method modifies a geometry of a fibriUated cartilage surface. A thermal energy delivery device is provided and includes a probe means with a distal end and a thermal energy delivery surface. A thermal energy source is also provided and coupled to the thermal energy delivery surface. The thermal energy delivery surface is positioned adjacent to the fibriUated cartilage surface in a non-contacting position. Sufficient thermal energy is delivered from the thermal energy delivery surface to reduce a level of fibrillation of the fibriUated cartilage surface.
The method and apparatus of the present invention can also be used to decrease the level of irregularity of an irregular cartilage surface.
The apparatus of the present invention may also include a sensor means positioned at the distal end of the probe means. A comparator means is provided and compares a measured temperature value at the sensor means with a predetermined temperature value. The comparator means generates a disabling signal if the measured temperature value exceeds the predetermined maximum temperature value. A communication means is provided and communicates the disabling signal to the thermal energy source means to cease further delivery of energy from the thermal energy source means to the first electrode means. In various embodiments of the invention, sufficient thermal energy is delivered from the thermal energy delivery surface to modify the fibriUated cartilage surface to a smooth surface. Thermal energy is delivered from the thermal energy delivery surface to create a less fibriUated, fibriUated cartilage surface. Thermal energy is delivered from the thermal energy delivery surface to cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to create a smoothened cartilage surface. Thermal energy is delivered from the thermal energy delivery surface to cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to melt onto the fibriUated cartilage surface. At least a portion of a plurality of cartilage strands are melted to create a smoothened cartilage surface.
A method according the invention includes the pre-cooling of tissue by means of an irrigating solution cooled to a very low temperature. The cooled solution is used to Lavage the joint for a period of time prior to the application of thermal therapeutic energy. It will be appreciated that such low temperatures decrease the temperature of the associated structures exposed within the field of the synovial cavity, thus providing a conventive thermal offset that will limit any temperature rise in response to any thermal energy applied to the tissue. The presence of the lower offset temperature protects the non-targeted tissue from collateral damage as a result of the thermal treatment.
A further understanding of the nature and advantages of the present invention will become apparent by reference to the following specification and drawings.
BRIEF DESCRIPTION OF THE FIGURES
A clear conception of the advantages and features constituting the invention, and of the components and operation of model systems provided with the invention, will become more readily apparent by referring to the exemplary, and therefore nonlimiting. embodiments illustrated in the drawings accompanying and forming a part of this specification, wherein like reference characters (if they occur in more than one view) designate the same parts. It should be noted that the features illustrated in the drawings are not necessarily drawn to scale.
The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the U.S. Patent and Trademark Office upon request and payment of the necessary fee.
Figure 1 is a perspective view of the apparatus of the present invention with a probe and two electrodes.
Figure 2 is a perspective view of the apparatus of the present invention with a probe, an electrode positioned at a distal end of the probe and two electrodes positioned on opposite sides of an insulator.
Figure 3 is a perspective view of a knee joint with chondromalacia.
Figure 4 is a perspective view of the apparatus of Figure 2 with a probe coiled distal end.
Figure 5 is a perspective view of the apparatus of the present invention with two electrodes positioned on opposite sides of an insulator.
Figure 6 is perspective view of the apparatus of the present invention including an electrode with radiused edges.
Figure 7 is a perspective view of the apparatus of the present invention including a rectangularly shaped electrode.
Figure 8 illustrates a perspective view of the apparatus of the present invention with electrodes formed on peripheral faces of the insulator.
Figure 9 is a cross-sectional view of the apparatus of Figure 8 taken along the lines 9-9.
Figure 10 is a perspective view of an electrode used with the apparatus of the present invention that is formed at a peripheral surface of the insulator and defines an interior non-conducting region. Figure 11 is a perspective view of a toroidal electrode used with the apparatus of the present invention and defines an interior non-conducting region.
Figure 12 is a perspective view of a non-circular toroidal electrode used with the apparatus, of the present invention and defines an interior nonconducting region.
Figure 13 is a perspective view of a segmented electrode used with the apparatus of the present invention.
Figure 14 is a perspective view of a segmented toroidal electrode used with the apparatus of the present invention.
Figure 15 is a perspective view of a flexible probe used with the apparatus of the present invention.
Figure 16 is a block diagram illustrating a feedback system useful to control the temperature of electrodes of the present invention.
Figure 17 illustrates a circuit useful to implement the feedback system of Figure 16.
Figs. 18A-18B illustrate two views of results obtained at 10°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
Figs. 19A-19B illustrate two views of results obtained at 15°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
Figs. 20A-20B illustrate two views of results obtained at 5°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention.
Figs. 21 A-21B illustrate two views of results obtained at 15°C Lavage, 40 watts and an 80°C probe temperature, representing an embodiment of the invention. Figs. 22A-22B illustrate two views of results obtained at 22°C Lavage, 20 watts and a 60°C probe temperature, representing an embodiment of the invention.
Figs. 23A-23B illustrate two views of results obtained at 37°C Lavage, 20 watts and a 60°C probe temperature, representing an embodiment of the invention.
DETAILED DESCRIPTION As shown in Figure 1, a thermal energy delivery apparatus 10 is configured to be positioned adjacent to, but spaced apart from a joint surface. Included is a probe 12 with a distal end 14, a first electrode 22 and a second electrode 24. Electrodes 22 and 24 can be operated in bipolar or monopolar. Bipolar is preferred. A distancing element 25 distances a thermal energy delivery surface of electrode 22 from the joint surface. Preferably, the thermal energy delivery surface of electrode 22, or of electrode 24, does not touch the joint surface. As illustrated in Figure 1, distancing element 25 is included. In other embodiments, distancing element 25 is not included and the thermal energy delivery surface of electrode 22 or of electrode 24 are positioned directly on the joint surface.
Refening now to Figure 2, thermal energy delivery apparatus 10 is configured to be positioned and deliver thermal energy to a joint surface. Apparatus 10 includes probe 12 with distal end 14 and an insulator 16 including first and second surfaces 18 and 20 formed on opposite sides on insulator 16. A pair of electrodes are also provided. First electrode 22 is positioned on first surface 18 of insulator 16. Second electrode 24 is positioned on second surface 20 of insulator 16. Thermal energy source 26 is coupled to first electrode 22 and second electrode 24 with a cable.
Insulator 16 can be an elongated structure with a longitudinal axis. Surfaces 18 and 20 can be parallel to each other. Insulator can be made of a variety of insulating materials known to those skilled in the art. Insulator 16 need not be one integral unit and surfaces 18 and 20 can be made of separate insulators that are separated. Surfaces 18 and 20 can be planar, non-planar and have geometries that conform closely to interior joint surfaces. In one embodiment, the dimensions of distal end 14 are sufficiently small to be positioned on a joint surface.
A knee joint surface 28 is shown in Figure 3. Knee joint surface 28 is defined by a first cartilage bed 30 formed at a distal end of the femur, and a second cartilage bed 32 formed at a distal end of the tibia. The present invention is not limited to the knee joint surface and can be used in a variety of different joint surfaces. Any joint surface susceptible to chondromalacia is treatable with apparatus 10. The present invention is suitable for the treatment of fibriUated cartilage joint surfaces to reduce the level of fibrillation and create smoother surfaces. The present invention is also used to treat irregular joint surfaces, where there are peaks and valleys, and create a less irregular joint surface. In certain embodiments, the irregular joint surface becomes a smooth joint surface.
A first plurality of cartilage strands 34 are coupled to first cartilage bed 30 and have become dislodged and dangle in joint surface 28. A second plurality of cartilage strands 36 are connected to second cartilage bed 32. Second plurality of cartilage strands 36 have also become dislodged and dangle in joint surface 28.
In one embodiment of the invention, a method is provided that modifies a geometry of a fibriUated cartilage surface. Sufficient thermal energy is delivered from first electrode 22 or second electrode 24 at different times to reduce a level of fibrillation of the fibriUated cartilage joint surface. In various embodiments of the invention, sufficient thermal energy is delivered electrode 22 or 24 to, (i) change the fibriUated cartilage surface to a smooth or smoother surface, (ii) reduce a level of fibrillation of the fibriUated cartilage surface, (iii) cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to create a smoothened cartilage surface, (iv) cause at least a portion of a plurality of cartilage strands coupled to the fibriUated cartilage surface to melt onto the fibriUated cartilage surface or (v) melt at least a portion of a plurality of cartilage strands to create a smoothened cartilage surface.
First electrode 22 has a first thermal energy delivery surface configured to deliver thermal energy to cartilage strands 34 and second electrode 24 has a second thermal energy delivery surface configured to deliver thermal energy to cartilage strands 36. Thermal energy includes but is not limited to RF, microwave, resistive heating, ultrasound, coherent or incoherent light and a thermal jet source. By delivering the appropriate amount of thermal energy to joint surface 28, strands 34 and 36 move out of joint surface 28 and the surfaces of cartilage beds 30 and 32 are smoothened. Additionally, delivered thermal energy can remove some or substantially all of cartilage strands 34 and 36 from joint surface 28. The delivery of thermal energy physically smoothes the surface of cartilage beds 30 and 32, changes the ultrastructure of the cartilage, stimulates cartilage replication and growth and changes the chemical environment in joint surface 28 and cartilage beds 30 and 32 to relieve pain.
Apparatus 10 is used to modify the geometry of cartilage strands 34 and 36 through cartilage shrinkage and possibly limited ablation of strands 34 and 36. Distal end 14 of probe 12 is inserted through an arthroscope to joint surface 28. First and second electrodes 22 and 24 are introduced into joint surface 28. Sufficient thermal energy is delivered from electrodes 22 and 24 to shrink at least a portion of cartilage strands 34 and 36, causing the strands to lie down on cartilage beds 30 and 32. The delivery of thermal energy to joint surface 28 results in an "ironing" of cartilage strands 34 and 36 onto cartilage beds 30 and 32. Sufficient thermal energy is delivered from first and- second electrodes 22 and 24 to shrink at least a portion of cartilage strands 34 and 36 without ablating more than 25% of cartilage beds 30 and 32. In one embodiment, sufficient energy is delivered by first and second electrodes 22 and 24 to raise the temperature of joint surface in the range of 45 to 90 degrees C, preferably 45 to 75 degrees C and more preferably 50 to 70 degrees C. Maintenance of a suitable temperature, and the delivery of thermal energy to joint surface 28, is sufficient to cause strands 34 and 36 to become at least partially melted onto the cartilage joint surface while minimizing ablation of cartilage beds 30 and 32.
Insulator 26 and first and second electrodes 22 and 24 are configured to be inserted into joint surface 28. Probe 12 is moved back and forth through joint surface 28 to deliver a sufficient amount of thermal energy to strands 34 and 36 to cause them to lie down on their respective cartilage beds. The thermal energy delivery surfaces of first and second electrodes 22 and 24 can move along the surfaces of cartilage beds 30 and 32 to complete the ironing effect.
Referring now to Figure 4, distal end 14 of probe 12 can have a coiled geometry as well as a variety of geometric configurations. Preferably, distal end 14 is malleable or sufficiently flexible to impart movement of first and second electrodes 22 and 24. Distal end 14 can pivot, be hinged, be articulated, or made of a shaped memory metal, and the like, in order to enable first and second electrodes 22 and 24 to follow the contours of joint surface 28.
As shown in Figure 5, first and second electrodes 22 and 24 can be operated in a bipolar mode. This concentrates the flow of RF energy between first and second electrodes 22 and 24 and diverts direct RF energy flow away from cartilage beds 30 and 32. RF energy which is directed between first and second electrodes 22 and 24 heats up fluids within joint surface 28 and provides a more controlled delivery of energy to cartilage strands 34 and 36. RF ablation of cartilage beds 30 and 32 is reduced. First and second electrodes 22 and 24 can have a variety of different geometric configurations. As illustrated in Figure 6, first and second electrodes 22 and 24 are symmetrically shaped with radiused edges. Elimination of sharp edges at an electrode surface reduce the creation of hot spots of thermal energy delivered to a site. In Figure 7, first and second electrodes 22 and 24 have rectangular geometries with non-radiused edges. First and second electrodes 22 and 24 can each have different sizes and geometries. First and second electrodes 22 and 24 can be mirror images of each other or they can be different.
Referring now to Figure 8, first and second electrodes 22 and 24 are formed on a periphery of insulation surfaces 18 and 20 respectively. In this embodiment, each electrode 22 and 24 defines a first and a second nonconducting region 38 and 40 on an insulator surface 18 and 20 within an interior of first and second electrodes 18 and 20. Non-conducting regions 38 and 40 can be the actual surface of insulator 16, or may be additional structures, each with a non-conducting surface, that are formed on insulation surfaces 18 and 20.
First and second sensors 42 and 44 can be provided and associated with first and second electrodes 22 and 24 to measure temperature and/or impedance. First and second sensors 42 and 44 are positioned on a surface of first and second electrodes 22 and 24, on a surface of probe 12, on non-conducting regions 38 and 40, or can be advanced and retracted from distal end 14 to and from joint surface 28.
First and second sensors 42 and 44 are of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like. Suitable thermal sensors 42 and 44 include a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like. Sensors 42 and 44 need not be thermal sensors.
Sensors 43 and; 44 measure temperature and/or impedance to permit monitoring and a desired level of energy delivered determined This reduces ablation damage to cartilage beds 30 and 32. If at any time sensor 42 or 44 determines that a desired temperature is exceeded, then an appropriate feedback signal is received at thermal energy source 26 which then regulates the amount of energy delivered to first and second electrodes 22 and 24.
Sensors 42 and 44 are positioned on non-conducting regions 38 and 40 in Figure 9. Non-conducting regions 38 and 40 have a variety of geometric surfaces including but not limited to planar, non-planar, concave, convex, and the like. In one embodiment, non-conducting regions 38 and 40 are closer to the midline of insulator 16 than first and second electrodes 22 and 24. This enhances the bipolar conduction of thermal energy between electrodes 22 and 24 in the bipolar mode of operation.
First and second electrodes 22 and 24 can have various geometries including but not limited to cylindrical, semi-cylindrical, rectangular, cubic, irregularly shaped, toroidal (Figure 10), non-circular toroidal (Figure 11), non- symmetrical, non-symmetrical toroidal (Figure 12) or be segmented and capable of multiplexing (Figures 13 and 14). In one embodiment, first electrode 22 has a toroidal geometry, first sensor 42 is positioned on non-conducting region 38, and distal end 14 is flexible and curved.
Figure 16 illustrates a block diagram of a temperature/impedance feedback system useful with apparatus 10. Thermal energy is delivered to first and second electrodes 22 and 24 by thermal energy source 26, and applied to cartilage strands 34 and 36. A monitor 56 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value a disabling signal 48 is transmitted to thermal energy source 26, ceasing further delivery of thermal energy to first and second electrodes 22 and 24. If measured impedance is within acceptable limits, energy continues to be applied. During the application of thermal energy to cartilage strands 34 and 36, sensor 42 measures the temperature at the surface of sensor 42. A comparator 50 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. Comparator 50 sends a signal to thermal energy source 26 to continue sending thermal energy, to increase or decrease the level of delivered thermal energy, or to cease delivery of thermal energy.
An output 52 from temperature comparator 50 can be input to thermal energy source 26 to regulate the amount of power delivered. Output 54 from impedance monitor 56 can be input control the temperature at joint surface 28.
Referring now to Figure 17, thermal energy source 26 is coupled to first and second electrodes 22 and 24 and apply a biologically safe voltage to cartilage strands 34 and 36. In the embodiment illustrated in Figure 11, apparatus 10 is represented as a bipolar ablation device. First and second electrodes 22 and 24 are connected to a primary side of transformer windings 58 and 60. The common primary windings 58 and 60 are magnetically coupled with a transformer core to secondary windings 58' and 60'.
The primary windings 58 of the first transformer t, couple the output voltage of apparatus 10 to the secondary windings 58'. The primary windings 60 of the second transformer t2 couple the output current of ablation apparatus 10 to the secondary windings 60'.
Measuring circuits determine the root mean square (RMS) values or magnitudes of the current and voltage. These values, represented as voltages, are inputted to a diving circuit D to geometrically calculate, by dividing the RMS voltage value by the RMS current value, the impedance of the tissue site at sensor 42.
The output voltage of the divider circuit D is presented at the positive (+) input terminal of comparator A. A voltage source V0 supplies a voltage across the variable resistor R^ thus allowing one to manually adjust the voltage presented at the negative input of comparator A. This voltage represents a maximum impedance value beyond which power will not be applied to electrode 22. Specifically, once the tissue is heated to a temperature corresponding to an impedance value greater than the maximum cut-off impedance, thermal energy source 26 stops supplying energy to first and second electrodes 22 and 24. Comparator A can be of any of a commercially available type that is able to control the amplitude or pulse width modulation of thermal energy source 26.
The temperature within joint surface 28 can be controlled based on the tissue impedance, as represented by signal 62, or based on tissue temperature, as represented by signal 64. In one embodiment, the switch S is activated to allow the impedance signal 62 to enter the positive (+) input terminal of comparator A. This signal along with the reference voltage applied to the negative (-) input terminal actuates comparator A to produce an output signal. If the selected tissue ablation site is heated to a biologically damaging temperature, the tissue impedance will exceed a selected impedance value seen at the negative (-) input terminal, thereby generating disabling signal 48 to disable thermal energy source 26, ceasing the energy supplied to first and second electrodes 22 and 24.
The output signal of comparator A may either disable thermal energy source's 26 energy output, depending on the tissue temperature as reflected by its impedance.
The thermal energy source 26 of apparatus 10 may also be used in combination with pre-cooling system 70 comprising a coolant source and a pump. The pre-cooling system 70 can be used to Lavage the joint with an irrigating solution which has been placed into a freezer or refrigerator to be chilled at or below 0°C before use in the surgical procedure. The irrigating solution lowers the joint surface and target tissue temperature for treatment below the typical body temperature of 37°C. Temperature sensor 46 is used to monitor the temperature of the tissue in the surgical field.
Because the entire surgical field is subjected to the irrigating solution, the pre-cooled thermal environment provides protection from collateral damage to non-targeted tissue. As thermal energy is applied from RF generator 34 to the primary winding 58 in the electrode of the apparatus, a thermal gradient is formed as the apparatus is placed near the joint surface for treatment. The thermal energy heats the joint surface and target tissue for a pre-determined amount of time to produce a desired ablation effect on the cartilage strands of the joint surface to smooth the surface during treatment. The targeted tissue strands are heated and ablated with reduced thermal effect on the underlying non-targeted joint surface. Thus, the chondrocytes in the articular cartilage surface remain viable and are minimally affected by the thermal energy from the apparatus during a surgical procedure.
FIGS. 18A-23B illustrate the in vitro studies of apparatus 10 utilizing a pre-cooling system 70 as shown in FIG. 17. All of the treated tissues shown in FIGS. 18A-23B were treated to substantially the same level of smoothness. All of the images shown in FIGS. 18A-23B at depicted at substantially the same magnification. The term approximately, as used herein, is defined as at least close to a given value (e.g., preferably within 10% of, more preferably within 1% of, and most preferably within 0.1% of). The term substantially, as used herein, is defined as at least approaching a given state (e.g., preferably within 10% of, more preferably within 1% of, and most preferably within 0.1% of). The term coupled, as used herein, is defined as connected, although not necessarily directly, and not necessarily mechanically.
FIGS. 18A-B illustrate a treatment with an irrigating solution at a temperature of approximately 10°C. FIG. 18A is a color microscopic cross-section of the articular cartilage surface 100 after pre-cooling treatment while FIG. 18B is a black and white representation for reference. The probe velocity was 1 mm/sec and applied with a motorized apparatus. Cell death is indicated by red with some staining artifacts remaining. As indicated, the irrigating solution was cooled to 10°C under 40W of power and a probe temperature of 80°C. The underlying articular cartilage bed 101 shows minimal cell death after thermal energy application along tissue surface 100 during treatment wherein viable chondrocytes are unaffected by the probe apparatus.
FIGS. 19A-B illustrate a treatment with an irrigating solution at a temperature of approximately 15 °C. FIG 19A is a color microscopic cross-section of the articular cartilage surface 110 after pre-cooling treatment while FIG. 19B is a black and white representation for reference. The probe velocity was 1 mm/sec and applied with a motorized apparatus. As indicated, the irrigating solution was cooled to 15°C under 40W of power and a probe temperature of 80°C. The underlying articular cartilage bed 111 shows minimal cell death along treated cartilage surface 100.
FIGS. 20A-B illustrate a treatment with an irrigating solution at a temperature of approximately 5 °C. FIG. 20A is a color microscopic cross-section of the articular cartilage surface 120 after pre-cooling treatment while FIG. 20B is a black and white representation for reference. The probe velocity was 1 mm/sec and applied with a motorized apparatus. As indicated, the irrigating solution was cooled to 5°C under 40 W of power and a probe temperature of 80°C. The underlying articular cartilage bed 121 shows minimal cell death along treated cartilage surface 120.
FIGS. 21 A-B illustrate a treatment with an irrigating solution at a temperature of approximately 15 °C. FIG.21 A is a color microscopic cross-section of the articular cartilage surface 200 after pre-cooling treatment while FIG. 21B is a black and white representation for reference. Hand pressure was used on the probe apparatus to test if physical insult and pressure in addition to the application of thermal energy to the target joint surface tissue would result in greater cell death to non-targeted tissue. As the hand pressure was increased on the articular cartilage surface 200, cell death due to physical pressures occurred as indicated by the central darkened zone with red stain. The irrigating solution was cooled to 15°C under 40W of power with a probe temperature of 80°C. However, since the joint and surgical field was pre-cooled, the non-targeted tissue 201 beyond where the physical pressure was applied to the articular cartilage illustrates protection from the thermal effect of the probe.
FIGS. 22A-B illustrate a treatment with an irrigating solution at a room temperature of approximately 22 °C. FIG.22A is a color microscopic cross-section of the articular cartilage surface 210 while FIG. 22B is a black and white representation for reference. Power was reduced to 20W while the probe temperature was reduced to 60°C. The probe velocity was Imm/sec and applied with a motorized apparatus. As the thermal energy was applied to the joint surface tissue 210, cell death occurred at both the treated surface 210 and below the tissue surface in area 215 of the articular cartilage 211 beyond the treatment area of articular cartilage surface 210.
FIGS. 23 A-B illustrate a treatment with an irrigating solution at a body temperature of approximately 37°C. FIG.23 A is a color microscopic cross-section of the articular cartilage surface 220 while FIG. 23 B is a black and white representation for reference. Power was reduced to 20W while the probe temperature was reduced to 60°C. The probe velocity was lmm/sec and applied with a motorized apparatus. As the thermal energy was applied to the joint surface tissue 220, significant cell death occurred along the tissue surface 220 and beyond and below the treatment area of articular cartilage surface 220 over a greater area 225 of the articular cartilage 221 as shown by the red stain. As illustrated, a larger tissue cartilage depth and lower probe temperature and power showed a greater effect and cell death from thermal insult than pre-cooled tissues at higher probe temperatures and powers as shown in FIGS. 18-21.
The arthroscopic set up includes an irrigating system, a viewing system and a positioning system in addition to the normal equipment utilized in a less invasive procedure conducted under general anesthesia. The irrigating system involves a fluid (irrigant) source (typically two liter bags of normal or isotonic saline), connecting tubing to include tubing clamps for mechanically inhibiting and controlling the flow of the irrigating solution, the percutaneous canula for insertion into the joint space to which the connecting tubing is attached providing the portal for irrigant supply, and a second portal or outflow port allowing irrigating fluid to exit the joint capsule which may have an extension tube to direct the outflow of the irrigant away from the operator. The irrigating solutions are commonly stored in the operating room and are then used at (room) stored temperature.
Either (or both) of these canulas may be incorporated into a canula system allowing the introduction of a "scope" (rod lens apparatus for viewing the interior of the joint space) or the introduction of all manner of interventional tools, to include probe cutters, electrosurgical and electrothermal instruments. Some surgeons utilize a pump system that senses intra-articular pressure and adequate hemostasis. Otherwise, the intra-articular (joint capsule) pressure is generated by elevating the solution bags above the level of the patient making use of a simple gravity supply.
The viewing system includes the arthroscopic "scope" (optical rod lens) to which is typically attached a clip on video camera that feeds a video signal to the camera base and a CRT monitor for viewing.
In experimental studies utilizing osteochondral specimens in a bovine model, significant protection against chondrocyte death was observed following precooling of the tissues to approximately 5°C. Protection against chondrocyte death was also observed following precooling of the tissues to approximately 10°C and approximately 15°C. Slight protection was even observed following precooling of the tissues to merely approximately 22°C, compared to the results obtained at approximately 37°C. In specimens that were not sufficiently precooled, cell death up to and including the full thickness of the cartilage treated and the underlying subchondral bone was observed when the superficial cartilage was thermally treated. These studies demonstrate that thermal sealing of the surface can be achieved with minimal cell death in the underlying cartilage.
A positioning system is selected, based upon the anatomy to be addressed with each procedure that is designed to immobilize or suspend the surgical site to facilitate the physician's access to the surgical field.
A preferred embodiment utilizes the standard arthroscopic system with the following modifications. The irrigating solution can cooled significantly by placing the solutions in a freezer or refrigerator. Because Normal Saline and Lactated Ringers Solution contain salts and sugars in solution they can be chilled to temperatures at or below 0°C without the concern of the solution freezing or forming crystals.
The invention can include the use of a subsystem including an irrigating solution reservoir coupled to a heat exchanger. The solution in the reservoir can thus be delivered to the non-targeted tissue at any temperature at any time, during even a lengthy procedure.
The invention can also utilize data processing methods that transform signals from solution to control the temperature of the solution. For example, the invention can be combined with instrumentation to obtain state variable information to actuate interconnected discrete hardware elements. For instance, the operation of the reservoir heat exchanger subsystem can be controlled by the use of one, or more, set point(s) in conjuction with an algorithm. The algorithm can gather state variable data such as a deviation of the temperature of the irrigating solution in the reservoir from the set point(s) and dynamic data such as the rate of change of the temperature of the irrigating solution in the reservoir. The algorithm can transform the set point(s), the state variable data and/or the dynamic data the into control signals that actuate the heat exchanger to control the temperature of the solution (e.g., start a pump in the heat exchanger to lower the temperature of the solution in the reservoir).
The invention can also be included in a kit. The kit can include some, or all, of the components that compose the invention. More specifically, the kit can include the probe, conduits for providing the solution to the non-targeted tissue and other components of the invention. The kit can also include the solution. The kit can also contain instructions for practicing the invention and apparatus for carrying out the invention. Unless otherwise specified, the components (and apparatus and/or instructions) of the kit can be the same as those used in the invention.
The cooled solution is used to "Lavage" the joint capsule for several minutes during the initial visual examination upon entering the joint before performing an intervention that will utilize a thermal device. Temperature of the solution exiting the outflow port can be monitored to assess the superficial intra-articular temperature by comparing the temperature of the in-flow irrigant with the temperature of the out-flow irrigant at low flow rates. In this way, the temperature of the tissues in the joint capsule and the tissues up to a centimeter away from the joint capsule can be cooled significantly.
Cooling the tissues in this way sets up a thermal gradient that offsets the thermal influence of the intervention. Both targeted and non-targeted tissues are cooled requiring an adjustment of the thermal probe accordingly and allowing for the use of higher temperatures spread away from the target area. The goal is to prevent temperature elevations in non-targeted tissues from exceeding 44°C. above which cell death occurs. In addition, since procedures in the peripheral joints and in particular in the knee, utilize a tourniquet system to control bleeding, the normal warming effects of vascularized tissue can be negated when the tourniquet is employed and greater cooling can be achieved that persists for a longer period of time. There are no untoward effects of cooling these ligamentous and bony structures to near freezing temperatures for a limited period of time.
The invention provides for the virtual elimination of thermal insult when compared to approaches that take no thermal defensive measures. The invention has the added benefit of greater heamostasis control even when a tourniquet is employed and even in the face of higher patient blood pressure. The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.

Claims

CLAIMSWhat is claims is:
1. A kit to protect non-targeted tissues in an arthroscopic environment comprising a thermal energy dehvery device including a probe with a distal end and a proximal end and a thermal energy delivery surface, a thermal energy source coupled to the thermal energy delivery surface and a conduit for providing a cooling irrigating solution to the arthroscopic environment.
2. The kit of Claim 1 further comprising a coolant source coupled to the conduit.
3. The kit of Claim 2 wherein said coolant source includes a solution reservoir and a heat exchanger coupled to the solution reservoir.
4. The apparatus of Claim 2 wherein said coolant source operates according to an algorithm that fransforrήs data concerning solution in said reservoir into signals that control the temperature of the solution in the reservoir.
5. The kit of Claim 1 further comprising an irrigating solution for deployment in the conduit.
6. The kit of Claim 1 further comprising instructions to protect non-targeted tissues in an arthroscopic environment.
7. An apparatus to protect non-targeted tissues in an arthroscopic environment, comprising a thermal energy delivery device including a probe with a distal end and a proximal end and a thermal energy delivery surface, a thermal energy source coupled to the thermal energy dehvery surface, and a conduit for providing a cooling irrigating solution to the arthroscopic environment.
8. The apparatus of Claim 7 further comprising a coolant source coupled to the conduit.
9. The apparatus of Claim 8 wherein said coolant source includes a solution reservoir and a heat exchanger coupled to the solution reservoir.
10. The apparatus of Claim 8 wherein said coolant source operates according to an dgorithm that transforms data concerning solution in said reservoir into signals that control the temperature of the solution in the reservoir.
11. The apparatus of Claim 7 further comprising an irrigating solution for deployment in the conduit.
PCT/US2000/035313 1999-12-31 2000-12-26 Thermal protection for methods of treating arthroscopic pathologies WO2001049196A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22927/01A AU2292701A (en) 1999-12-31 2000-12-26 Thermal protection for methods of treating arthroscopic pathologies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/476,018 1999-12-31
US09/476,018 US6544260B1 (en) 1996-08-20 1999-12-31 Method for treating tissue in arthroscopic environment using precooling and apparatus for same

Publications (2)

Publication Number Publication Date
WO2001049196A1 WO2001049196A1 (en) 2001-07-12
WO2001049196A9 true WO2001049196A9 (en) 2002-05-23

Family

ID=23890162

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/035313 WO2001049196A1 (en) 1999-12-31 2000-12-26 Thermal protection for methods of treating arthroscopic pathologies

Country Status (3)

Country Link
US (1) US6544260B1 (en)
AU (1) AU2292701A (en)
WO (1) WO2001049196A1 (en)

Families Citing this family (236)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050187599A1 (en) * 1994-05-06 2005-08-25 Hugh Sharkey Method and apparatus for controlled contraction of soft tissue
US6033399A (en) * 1997-04-09 2000-03-07 Valleylab, Inc. Electrosurgical generator with adaptive power control
US20030178032A1 (en) * 1997-08-13 2003-09-25 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
JP2001514921A (en) * 1997-08-13 2001-09-18 サークス, インコーポレイテッド Non-invasive devices, methods, and systems for tissue contraction
US7695470B1 (en) 1998-08-12 2010-04-13 Maquet Cardiovascular Llc Integrated vessel ligator and transector
EP0979635A2 (en) 1998-08-12 2000-02-16 Origin Medsystems, Inc. Tissue dissector apparatus
US7534243B1 (en) * 1998-08-12 2009-05-19 Maquet Cardiovascular Llc Dissection and welding of tissue
US7137980B2 (en) 1998-10-23 2006-11-21 Sherwood Services Ag Method and system for controlling output of RF medical generator
US7364577B2 (en) 2002-02-11 2008-04-29 Sherwood Services Ag Vessel sealing system
US7901400B2 (en) 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
US7306591B2 (en) 2000-10-02 2007-12-11 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence
US6558313B1 (en) 2000-11-17 2003-05-06 Embro Corporation Vein harvesting system and method
US11229472B2 (en) 2001-06-12 2022-01-25 Cilag Gmbh International Modular battery powered handheld surgical instrument with multiple magnetic position sensors
US6757565B2 (en) * 2002-02-08 2004-06-29 Oratec Interventions, Inc. Electrosurgical instrument having a predetermined heat profile
CA2475901A1 (en) * 2002-02-12 2003-08-21 Oratec Interventions, Inc. Radiofrequency arthroscopic ablation device
US7044948B2 (en) 2002-12-10 2006-05-16 Sherwood Services Ag Circuit for controlling arc energy from an electrosurgical generator
US7722601B2 (en) 2003-05-01 2010-05-25 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US8104956B2 (en) 2003-10-23 2012-01-31 Covidien Ag Thermocouple measurement circuit
US7396336B2 (en) 2003-10-30 2008-07-08 Sherwood Services Ag Switched resonant ultrasonic power amplifier system
US7131860B2 (en) 2003-11-20 2006-11-07 Sherwood Services Ag Connector systems for electrosurgical generator
JP2007519498A (en) 2004-01-30 2007-07-19 エヌエムティー メディカル, インコーポレイティッド Devices, systems, and methods for closure of cardiac openings
US8182501B2 (en) 2004-02-27 2012-05-22 Ethicon Endo-Surgery, Inc. Ultrasonic surgical shears and method for sealing a blood vessel using same
JP5009159B2 (en) 2004-10-08 2012-08-22 エシコン・エンド−サージェリィ・インコーポレイテッド Ultrasonic surgical instrument
US7628786B2 (en) 2004-10-13 2009-12-08 Covidien Ag Universal foot switch contact port
US7536225B2 (en) * 2005-01-21 2009-05-19 Ams Research Corporation Endo-pelvic fascia penetrating heating systems and methods for incontinence treatment
US9474564B2 (en) 2005-03-31 2016-10-25 Covidien Ag Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator
US9259267B2 (en) 2005-09-06 2016-02-16 W.L. Gore & Associates, Inc. Devices and methods for treating cardiac tissue
WO2007030433A2 (en) 2005-09-06 2007-03-15 Nmt Medical, Inc. Removable intracardiac rf device
US8852184B2 (en) * 2005-09-15 2014-10-07 Cannuflow, Inc. Arthroscopic surgical temperature control system
US20070088388A1 (en) * 2005-09-19 2007-04-19 Opolski Steven W Delivery device for implant with dual attachment sites
US20070191713A1 (en) 2005-10-14 2007-08-16 Eichmann Stephen E Ultrasonic device for cutting and coagulating
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
US7621930B2 (en) 2006-01-20 2009-11-24 Ethicon Endo-Surgery, Inc. Ultrasound medical instrument having a medical ultrasonic blade
CA2575392C (en) * 2006-01-24 2015-07-07 Sherwood Services Ag System and method for tissue sealing
US7513896B2 (en) 2006-01-24 2009-04-07 Covidien Ag Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling
US8685016B2 (en) 2006-01-24 2014-04-01 Covidien Ag System and method for tissue sealing
US8216223B2 (en) 2006-01-24 2012-07-10 Covidien Ag System and method for tissue sealing
CA2574934C (en) 2006-01-24 2015-12-29 Sherwood Services Ag System and method for closed loop monitoring of monopolar electrosurgical apparatus
US8147485B2 (en) 2006-01-24 2012-04-03 Covidien Ag System and method for tissue sealing
US9186200B2 (en) 2006-01-24 2015-11-17 Covidien Ag System and method for tissue sealing
CA2574935A1 (en) 2006-01-24 2007-07-24 Sherwood Services Ag A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
WO2017037789A1 (en) * 2015-08-28 2017-03-09 オリンパス株式会社 Surgery system and operation method for surgery system
US7651492B2 (en) 2006-04-24 2010-01-26 Covidien Ag Arc based adaptive control system for an electrosurgical unit
US9770230B2 (en) 2006-06-01 2017-09-26 Maquet Cardiovascular Llc Endoscopic vessel harvesting system components
US7794457B2 (en) 2006-09-28 2010-09-14 Covidien Ag Transformer for RF voltage sensing
US8911460B2 (en) 2007-03-22 2014-12-16 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US8226675B2 (en) * 2007-03-22 2012-07-24 Ethicon Endo-Surgery, Inc. Surgical instruments
US8142461B2 (en) 2007-03-22 2012-03-27 Ethicon Endo-Surgery, Inc. Surgical instruments
US8057498B2 (en) 2007-11-30 2011-11-15 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instrument blades
US20080234709A1 (en) 2007-03-22 2008-09-25 Houser Kevin L Ultrasonic surgical instrument and cartilage and bone shaping blades therefor
US8777941B2 (en) 2007-05-10 2014-07-15 Covidien Lp Adjustable impedance electrosurgical electrodes
US7834484B2 (en) * 2007-07-16 2010-11-16 Tyco Healthcare Group Lp Connection cable and method for activating a voltage-controlled generator
US8808319B2 (en) 2007-07-27 2014-08-19 Ethicon Endo-Surgery, Inc. Surgical instruments
US8348967B2 (en) 2007-07-27 2013-01-08 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US8257377B2 (en) * 2007-07-27 2012-09-04 Ethicon Endo-Surgery, Inc. Multiple end effectors ultrasonic surgical instruments
US8882791B2 (en) 2007-07-27 2014-11-11 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US8523889B2 (en) 2007-07-27 2013-09-03 Ethicon Endo-Surgery, Inc. Ultrasonic end effectors with increased active length
US8252012B2 (en) 2007-07-31 2012-08-28 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instrument with modulator
US8430898B2 (en) 2007-07-31 2013-04-30 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US9044261B2 (en) 2007-07-31 2015-06-02 Ethicon Endo-Surgery, Inc. Temperature controlled ultrasonic surgical instruments
US8512365B2 (en) 2007-07-31 2013-08-20 Ethicon Endo-Surgery, Inc. Surgical instruments
US8216220B2 (en) 2007-09-07 2012-07-10 Tyco Healthcare Group Lp System and method for transmission of combined data stream
US8512332B2 (en) 2007-09-21 2013-08-20 Covidien Lp Real-time arc control in electrosurgical generators
USD594983S1 (en) 2007-10-05 2009-06-23 Ethicon Endo-Surgery, Inc. Handle assembly for surgical instrument
US8623027B2 (en) 2007-10-05 2014-01-07 Ethicon Endo-Surgery, Inc. Ergonomic surgical instruments
US10010339B2 (en) 2007-11-30 2018-07-03 Ethicon Llc Ultrasonic surgical blades
US7901423B2 (en) 2007-11-30 2011-03-08 Ethicon Endo-Surgery, Inc. Folded ultrasonic end effectors with increased active length
US8106829B2 (en) * 2007-12-12 2012-01-31 Broadcom Corporation Method and system for an integrated antenna and antenna management
US8226639B2 (en) 2008-06-10 2012-07-24 Tyco Healthcare Group Lp System and method for output control of electrosurgical generator
US8058771B2 (en) 2008-08-06 2011-11-15 Ethicon Endo-Surgery, Inc. Ultrasonic device for cutting and coagulating with stepped output
US9089360B2 (en) 2008-08-06 2015-07-28 Ethicon Endo-Surgery, Inc. Devices and techniques for cutting and coagulating tissue
US8262652B2 (en) 2009-01-12 2012-09-11 Tyco Healthcare Group Lp Imaginary impedance process monitoring and intelligent shut-off
US8167875B2 (en) * 2009-01-12 2012-05-01 Tyco Healthcare Group Lp Energy delivery algorithm for medical devices
US8333759B2 (en) * 2009-01-12 2012-12-18 Covidien Lp Energy delivery algorithm for medical devices
US8211100B2 (en) * 2009-01-12 2012-07-03 Tyco Healthcare Group Lp Energy delivery algorithm for medical devices based on maintaining a fixed position on a tissue electrical conductivity v. temperature curve
US9700339B2 (en) 2009-05-20 2017-07-11 Ethicon Endo-Surgery, Inc. Coupling arrangements and methods for attaching tools to ultrasonic surgical instruments
US8344596B2 (en) 2009-06-24 2013-01-01 Ethicon Endo-Surgery, Inc. Transducer arrangements for ultrasonic surgical instruments
US8461744B2 (en) 2009-07-15 2013-06-11 Ethicon Endo-Surgery, Inc. Rotating transducer mount for ultrasonic surgical instruments
US9017326B2 (en) 2009-07-15 2015-04-28 Ethicon Endo-Surgery, Inc. Impedance monitoring apparatus, system, and method for ultrasonic surgical instruments
US8663220B2 (en) 2009-07-15 2014-03-04 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US8652125B2 (en) * 2009-09-28 2014-02-18 Covidien Lp Electrosurgical generator user interface
US9168054B2 (en) 2009-10-09 2015-10-27 Ethicon Endo-Surgery, Inc. Surgical generator for ultrasonic and electrosurgical devices
US8986302B2 (en) 2009-10-09 2015-03-24 Ethicon Endo-Surgery, Inc. Surgical generator for ultrasonic and electrosurgical devices
US10172669B2 (en) 2009-10-09 2019-01-08 Ethicon Llc Surgical instrument comprising an energy trigger lockout
USRE47996E1 (en) 2009-10-09 2020-05-19 Ethicon Llc Surgical generator for ultrasonic and electrosurgical devices
US10441345B2 (en) 2009-10-09 2019-10-15 Ethicon Llc Surgical generator for ultrasonic and electrosurgical devices
US11090104B2 (en) 2009-10-09 2021-08-17 Cilag Gmbh International Surgical generator for ultrasonic and electrosurgical devices
US9259234B2 (en) 2010-02-11 2016-02-16 Ethicon Endo-Surgery, Llc Ultrasonic surgical instruments with rotatable blade and hollow sheath arrangements
US8951272B2 (en) 2010-02-11 2015-02-10 Ethicon Endo-Surgery, Inc. Seal arrangements for ultrasonically powered surgical instruments
US8579928B2 (en) 2010-02-11 2013-11-12 Ethicon Endo-Surgery, Inc. Outer sheath and blade arrangements for ultrasonic surgical instruments
US8961547B2 (en) 2010-02-11 2015-02-24 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments with moving cutting implement
US8531064B2 (en) 2010-02-11 2013-09-10 Ethicon Endo-Surgery, Inc. Ultrasonically powered surgical instruments with rotating cutting implement
US8323302B2 (en) 2010-02-11 2012-12-04 Ethicon Endo-Surgery, Inc. Methods of using ultrasonically powered surgical instruments with rotatable cutting implements
US8382782B2 (en) 2010-02-11 2013-02-26 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments with partially rotating blade and fixed pad arrangement
US8469981B2 (en) 2010-02-11 2013-06-25 Ethicon Endo-Surgery, Inc. Rotatable cutting implement arrangements for ultrasonic surgical instruments
US8486096B2 (en) 2010-02-11 2013-07-16 Ethicon Endo-Surgery, Inc. Dual purpose surgical instrument for cutting and coagulating tissue
US8419759B2 (en) 2010-02-11 2013-04-16 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instrument with comb-like tissue trimming device
GB2480498A (en) 2010-05-21 2011-11-23 Ethicon Endo Surgery Inc Medical device comprising RF circuitry
US8795327B2 (en) 2010-07-22 2014-08-05 Ethicon Endo-Surgery, Inc. Electrosurgical instrument with separate closure and cutting members
US9192431B2 (en) 2010-07-23 2015-11-24 Ethicon Endo-Surgery, Inc. Electrosurgical cutting and sealing instrument
US8979890B2 (en) 2010-10-01 2015-03-17 Ethicon Endo-Surgery, Inc. Surgical instrument with jaw member
US8888809B2 (en) 2010-10-01 2014-11-18 Ethicon Endo-Surgery, Inc. Surgical instrument with jaw member
US8968293B2 (en) 2011-04-12 2015-03-03 Covidien Lp Systems and methods for calibrating power measurements in an electrosurgical generator
US9259265B2 (en) 2011-07-22 2016-02-16 Ethicon Endo-Surgery, Llc Surgical instruments for tensioning tissue
USD700967S1 (en) 2011-08-23 2014-03-11 Covidien Ag Handle for portable surgical device
US9033973B2 (en) 2011-08-30 2015-05-19 Covidien Lp System and method for DC tissue impedance sensing
US9314292B2 (en) 2011-10-24 2016-04-19 Ethicon Endo-Surgery, Llc Trigger lockout mechanism
USD687549S1 (en) 2011-10-24 2013-08-06 Ethicon Endo-Surgery, Inc. Surgical instrument
US10076383B2 (en) 2012-01-25 2018-09-18 Covidien Lp Electrosurgical device having a multiplexer
EP2811932B1 (en) 2012-02-10 2019-06-26 Ethicon LLC Robotically controlled surgical instrument
US9226766B2 (en) 2012-04-09 2016-01-05 Ethicon Endo-Surgery, Inc. Serial communication protocol for medical device
US9241731B2 (en) 2012-04-09 2016-01-26 Ethicon Endo-Surgery, Inc. Rotatable electrical connection for ultrasonic surgical instruments
US9439668B2 (en) 2012-04-09 2016-09-13 Ethicon Endo-Surgery, Llc Switch arrangements for ultrasonic surgical instruments
US9237921B2 (en) 2012-04-09 2016-01-19 Ethicon Endo-Surgery, Inc. Devices and techniques for cutting and coagulating tissue
US9724118B2 (en) 2012-04-09 2017-08-08 Ethicon Endo-Surgery, Llc Techniques for cutting and coagulating tissue for ultrasonic surgical instruments
US20140005705A1 (en) 2012-06-29 2014-01-02 Ethicon Endo-Surgery, Inc. Surgical instruments with articulating shafts
US9351754B2 (en) 2012-06-29 2016-05-31 Ethicon Endo-Surgery, Llc Ultrasonic surgical instruments with distally positioned jaw assemblies
US9198714B2 (en) 2012-06-29 2015-12-01 Ethicon Endo-Surgery, Inc. Haptic feedback devices for surgical robot
US9408622B2 (en) 2012-06-29 2016-08-09 Ethicon Endo-Surgery, Llc Surgical instruments with articulating shafts
US9326788B2 (en) 2012-06-29 2016-05-03 Ethicon Endo-Surgery, Llc Lockout mechanism for use with robotic electrosurgical device
US9393037B2 (en) 2012-06-29 2016-07-19 Ethicon Endo-Surgery, Llc Surgical instruments with articulating shafts
US20140005702A1 (en) 2012-06-29 2014-01-02 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments with distally positioned transducers
US9820768B2 (en) 2012-06-29 2017-11-21 Ethicon Llc Ultrasonic surgical instruments with control mechanisms
US9283045B2 (en) 2012-06-29 2016-03-15 Ethicon Endo-Surgery, Llc Surgical instruments with fluid management system
US9226767B2 (en) 2012-06-29 2016-01-05 Ethicon Endo-Surgery, Inc. Closed feedback control for electrosurgical device
BR112015007010B1 (en) 2012-09-28 2022-05-31 Ethicon Endo-Surgery, Inc end actuator
US10201365B2 (en) 2012-10-22 2019-02-12 Ethicon Llc Surgeon feedback sensing and display methods
US9095367B2 (en) 2012-10-22 2015-08-04 Ethicon Endo-Surgery, Inc. Flexible harmonic waveguides/blades for surgical instruments
US20140135804A1 (en) 2012-11-15 2014-05-15 Ethicon Endo-Surgery, Inc. Ultrasonic and electrosurgical devices
US10226273B2 (en) 2013-03-14 2019-03-12 Ethicon Llc Mechanical fasteners for use with surgical energy devices
US9241728B2 (en) 2013-03-15 2016-01-26 Ethicon Endo-Surgery, Inc. Surgical instrument with multiple clamping mechanisms
US9872719B2 (en) 2013-07-24 2018-01-23 Covidien Lp Systems and methods for generating electrosurgical energy using a multistage power converter
US9636165B2 (en) 2013-07-29 2017-05-02 Covidien Lp Systems and methods for measuring tissue impedance through an electrosurgical cable
US9814514B2 (en) 2013-09-13 2017-11-14 Ethicon Llc Electrosurgical (RF) medical instruments for cutting and coagulating tissue
US9265926B2 (en) 2013-11-08 2016-02-23 Ethicon Endo-Surgery, Llc Electrosurgical devices
GB2521229A (en) 2013-12-16 2015-06-17 Ethicon Endo Surgery Inc Medical device
GB2521228A (en) 2013-12-16 2015-06-17 Ethicon Endo Surgery Inc Medical device
US9795436B2 (en) 2014-01-07 2017-10-24 Ethicon Llc Harvesting energy from a surgical generator
US9554854B2 (en) 2014-03-18 2017-01-31 Ethicon Endo-Surgery, Llc Detecting short circuits in electrosurgical medical devices
US10463421B2 (en) 2014-03-27 2019-11-05 Ethicon Llc Two stage trigger, clamp and cut bipolar vessel sealer
US10092310B2 (en) 2014-03-27 2018-10-09 Ethicon Llc Electrosurgical devices
US9737355B2 (en) 2014-03-31 2017-08-22 Ethicon Llc Controlling impedance rise in electrosurgical medical devices
US9913680B2 (en) 2014-04-15 2018-03-13 Ethicon Llc Software algorithms for electrosurgical instruments
US9700333B2 (en) 2014-06-30 2017-07-11 Ethicon Llc Surgical instrument with variable tissue compression
US10285724B2 (en) 2014-07-31 2019-05-14 Ethicon Llc Actuation mechanisms and load adjustment assemblies for surgical instruments
WO2016070013A1 (en) 2014-10-31 2016-05-06 Medtronic Advanced Energy Llc Fingerswitch circuitry to reduce rf leakage current
US10639092B2 (en) 2014-12-08 2020-05-05 Ethicon Llc Electrode configurations for surgical instruments
US10159524B2 (en) 2014-12-22 2018-12-25 Ethicon Llc High power battery powered RF amplifier topology
US10245095B2 (en) 2015-02-06 2019-04-02 Ethicon Llc Electrosurgical instrument with rotation and articulation mechanisms
US10342602B2 (en) 2015-03-17 2019-07-09 Ethicon Llc Managing tissue treatment
US10321950B2 (en) 2015-03-17 2019-06-18 Ethicon Llc Managing tissue treatment
US10595929B2 (en) 2015-03-24 2020-03-24 Ethicon Llc Surgical instruments with firing system overload protection mechanisms
US10314638B2 (en) 2015-04-07 2019-06-11 Ethicon Llc Articulating radio frequency (RF) tissue seal with articulating state sensing
US10034684B2 (en) 2015-06-15 2018-07-31 Ethicon Llc Apparatus and method for dissecting and coagulating tissue
US11020140B2 (en) 2015-06-17 2021-06-01 Cilag Gmbh International Ultrasonic surgical blade for use with ultrasonic surgical instruments
US10357303B2 (en) 2015-06-30 2019-07-23 Ethicon Llc Translatable outer tube for sealing using shielded lap chole dissector
US11051873B2 (en) 2015-06-30 2021-07-06 Cilag Gmbh International Surgical system with user adaptable techniques employing multiple energy modalities based on tissue parameters
US11141213B2 (en) 2015-06-30 2021-10-12 Cilag Gmbh International Surgical instrument with user adaptable techniques
US10898256B2 (en) 2015-06-30 2021-01-26 Ethicon Llc Surgical system with user adaptable techniques based on tissue impedance
US11129669B2 (en) 2015-06-30 2021-09-28 Cilag Gmbh International Surgical system with user adaptable techniques based on tissue type
US10034704B2 (en) 2015-06-30 2018-07-31 Ethicon Llc Surgical instrument with user adaptable algorithms
US10154852B2 (en) 2015-07-01 2018-12-18 Ethicon Llc Ultrasonic surgical blade with improved cutting and coagulation features
WO2017037790A1 (en) * 2015-08-28 2017-03-09 オリンパス株式会社 Ultrasonic surgery system and method for operating ultrasonic surgery system
US10201366B2 (en) * 2015-09-28 2019-02-12 Olympus Corporation Treatment method
US20170086874A1 (en) * 2015-09-28 2017-03-30 Olympus Corporation Treatment method using ultrasonic surgical system
US10194932B2 (en) * 2015-09-28 2019-02-05 Olympus Corporation Treatment method
US10265549B2 (en) * 2015-09-28 2019-04-23 Olympus Corporation Treatment method
US11033322B2 (en) 2015-09-30 2021-06-15 Ethicon Llc Circuit topologies for combined generator
US10052119B2 (en) 2015-10-08 2018-08-21 Olympus Corporation Knee joint surgical treatment
US10383642B2 (en) 2015-10-08 2019-08-20 Olympus Corporation Surgical procedure of knee joint
US9924962B2 (en) 2015-10-08 2018-03-27 Olympus Corporation Elbow joint surgical treatment
US10080577B2 (en) 2015-10-08 2018-09-25 Olympus Corporation Joint surgical treatment
US10028755B2 (en) 2015-10-08 2018-07-24 Olympus Corporation Knee joint surgical treatment
US10052118B2 (en) 2015-10-08 2018-08-21 Olympus Corporation Knee joint surgical treatment
US10052117B2 (en) 2015-10-08 2018-08-21 Olympus Corporation Joint surgical treatment
US10595930B2 (en) 2015-10-16 2020-03-24 Ethicon Llc Electrode wiping surgical device
US10959771B2 (en) 2015-10-16 2021-03-30 Ethicon Llc Suction and irrigation sealing grasper
US10959806B2 (en) 2015-12-30 2021-03-30 Ethicon Llc Energized medical device with reusable handle
US10179022B2 (en) 2015-12-30 2019-01-15 Ethicon Llc Jaw position impedance limiter for electrosurgical instrument
US10575892B2 (en) 2015-12-31 2020-03-03 Ethicon Llc Adapter for electrical surgical instruments
US11051840B2 (en) 2016-01-15 2021-07-06 Ethicon Llc Modular battery powered handheld surgical instrument with reusable asymmetric handle housing
US11229471B2 (en) 2016-01-15 2022-01-25 Cilag Gmbh International Modular battery powered handheld surgical instrument with selective application of energy based on tissue characterization
US11129670B2 (en) 2016-01-15 2021-09-28 Cilag Gmbh International Modular battery powered handheld surgical instrument with selective application of energy based on button displacement, intensity, or local tissue characterization
US10716615B2 (en) 2016-01-15 2020-07-21 Ethicon Llc Modular battery powered handheld surgical instrument with curved end effectors having asymmetric engagement between jaw and blade
US10555769B2 (en) 2016-02-22 2020-02-11 Ethicon Llc Flexible circuits for electrosurgical instrument
JP6596577B2 (en) * 2016-03-31 2019-10-23 オリンパス株式会社 Ultrasound treatment system for joints
US10478160B1 (en) * 2016-04-21 2019-11-19 Christopher M. Mooney Technologies for cartilage harvesting
US10987156B2 (en) 2016-04-29 2021-04-27 Ethicon Llc Electrosurgical instrument with electrically conductive gap setting member and electrically insulative tissue engaging members
US10856934B2 (en) 2016-04-29 2020-12-08 Ethicon Llc Electrosurgical instrument with electrically conductive gap setting and tissue engaging members
US10646269B2 (en) 2016-04-29 2020-05-12 Ethicon Llc Non-linear jaw gap for electrosurgical instruments
US10702329B2 (en) 2016-04-29 2020-07-07 Ethicon Llc Jaw structure with distal post for electrosurgical instruments
US10485607B2 (en) 2016-04-29 2019-11-26 Ethicon Llc Jaw structure with distal closure for electrosurgical instruments
US10456193B2 (en) 2016-05-03 2019-10-29 Ethicon Llc Medical device with a bilateral jaw configuration for nerve stimulation
US10245064B2 (en) 2016-07-12 2019-04-02 Ethicon Llc Ultrasonic surgical instrument with piezoelectric central lumen transducer
US10893883B2 (en) 2016-07-13 2021-01-19 Ethicon Llc Ultrasonic assembly for use with ultrasonic surgical instruments
US10842522B2 (en) 2016-07-15 2020-11-24 Ethicon Llc Ultrasonic surgical instruments having offset blades
US10376305B2 (en) 2016-08-05 2019-08-13 Ethicon Llc Methods and systems for advanced harmonic energy
US10285723B2 (en) 2016-08-09 2019-05-14 Ethicon Llc Ultrasonic surgical blade with improved heel portion
USD847990S1 (en) 2016-08-16 2019-05-07 Ethicon Llc Surgical instrument
US10952759B2 (en) 2016-08-25 2021-03-23 Ethicon Llc Tissue loading of a surgical instrument
US10828056B2 (en) 2016-08-25 2020-11-10 Ethicon Llc Ultrasonic transducer to waveguide acoustic coupling, connections, and configurations
US20180071012A1 (en) * 2016-09-15 2018-03-15 Cannuflow, Inc. Method of performing arthroscopic surgery
US10751117B2 (en) 2016-09-23 2020-08-25 Ethicon Llc Electrosurgical instrument with fluid diverter
US20180116784A1 (en) 2016-10-28 2018-05-03 Olympus Corporation Surgical procedure of knee joint
DE102016012941B4 (en) 2016-10-28 2019-06-06 Mvo Gmbh Metallverarbeitung Ostalb Process for machining a toothed rack and subsequently machined rack
US10603064B2 (en) 2016-11-28 2020-03-31 Ethicon Llc Ultrasonic transducer
US11266430B2 (en) 2016-11-29 2022-03-08 Cilag Gmbh International End effector control and calibration
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
US11033325B2 (en) 2017-02-16 2021-06-15 Cilag Gmbh International Electrosurgical instrument with telescoping suction port and debris cleaner
US10799284B2 (en) 2017-03-15 2020-10-13 Ethicon Llc Electrosurgical instrument with textured jaws
US11497546B2 (en) 2017-03-31 2022-11-15 Cilag Gmbh International Area ratios of patterned coatings on RF electrodes to reduce sticking
US10603117B2 (en) 2017-06-28 2020-03-31 Ethicon Llc Articulation state detection mechanisms
US10820920B2 (en) 2017-07-05 2020-11-03 Ethicon Llc Reusable ultrasonic medical devices and methods of their use
US11490951B2 (en) 2017-09-29 2022-11-08 Cilag Gmbh International Saline contact with electrodes
US11033323B2 (en) 2017-09-29 2021-06-15 Cilag Gmbh International Systems and methods for managing fluid and suction in electrosurgical systems
US11484358B2 (en) 2017-09-29 2022-11-01 Cilag Gmbh International Flexible electrosurgical instrument
US11812957B2 (en) 2019-12-30 2023-11-14 Cilag Gmbh International Surgical instrument comprising a signal interference resolution system
US11452525B2 (en) 2019-12-30 2022-09-27 Cilag Gmbh International Surgical instrument comprising an adjustment system
US11744636B2 (en) 2019-12-30 2023-09-05 Cilag Gmbh International Electrosurgical systems with integrated and external power sources
US11950797B2 (en) 2019-12-30 2024-04-09 Cilag Gmbh International Deflectable electrode with higher distal bias relative to proximal bias
US11786291B2 (en) 2019-12-30 2023-10-17 Cilag Gmbh International Deflectable support of RF energy electrode with respect to opposing ultrasonic blade
US11944366B2 (en) 2019-12-30 2024-04-02 Cilag Gmbh International Asymmetric segmented ultrasonic support pad for cooperative engagement with a movable RF electrode
US20210196361A1 (en) 2019-12-30 2021-07-01 Ethicon Llc Electrosurgical instrument with monopolar and bipolar energy capabilities
US11786294B2 (en) 2019-12-30 2023-10-17 Cilag Gmbh International Control program for modular combination energy device
US11779329B2 (en) 2019-12-30 2023-10-10 Cilag Gmbh International Surgical instrument comprising a flex circuit including a sensor system
US11779387B2 (en) 2019-12-30 2023-10-10 Cilag Gmbh International Clamp arm jaw to minimize tissue sticking and improve tissue control
US11660089B2 (en) 2019-12-30 2023-05-30 Cilag Gmbh International Surgical instrument comprising a sensing system
US11696776B2 (en) 2019-12-30 2023-07-11 Cilag Gmbh International Articulatable surgical instrument
US11937863B2 (en) 2019-12-30 2024-03-26 Cilag Gmbh International Deflectable electrode with variable compression bias along the length of the deflectable electrode
US11937866B2 (en) 2019-12-30 2024-03-26 Cilag Gmbh International Method for an electrosurgical procedure
US11911063B2 (en) 2019-12-30 2024-02-27 Cilag Gmbh International Techniques for detecting ultrasonic blade to electrode contact and reducing power to ultrasonic blade
US11684412B2 (en) 2019-12-30 2023-06-27 Cilag Gmbh International Surgical instrument with rotatable and articulatable surgical end effector
DE102020117810A1 (en) * 2020-07-07 2022-01-13 Olympus Winter & Ibe Gmbh High frequency electrode for use in a surgical handheld device, electrode instrument and resectoscope

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1314855A (en) 1919-09-02 Surgical instrument
US300155A (en) 1884-06-10 stabr
US164184A (en) 1875-06-08 Improvement in vesicular electrodes
US452220A (en) 1891-05-12 gunning
US371664A (en) 1887-10-18 stone
US1366756A (en) 1919-02-12 1921-01-25 Wappler Electric Company Inc Cautery-electrode
US1731627A (en) 1927-06-06 1929-10-15 Carl J Johnson Electrotherapeutical instrument
US1735271A (en) 1928-03-14 1929-11-12 Sutten H Groff Diathermy knife
US1814791A (en) 1928-05-04 1931-07-14 Frank M Ende Diathermy
US1908583A (en) 1929-09-13 1933-05-09 Reinhold H Wappler Diathermic electrode
US1916722A (en) 1931-06-15 1933-07-04 Frank M Ende Diathermy
US1932258A (en) 1931-09-02 1933-10-24 Wappler Frederick Charles Surgical electrode
US1943543A (en) 1932-06-21 1934-01-16 William J Mcfadden Surgical instrument
US2004559A (en) 1932-11-22 1935-06-11 Wappler Frederick Charles Method and instrument for electrosurgical treatment of tissue
US2002594A (en) 1933-03-24 1935-05-28 Wappler Frederick Charles Instrument for electro-surgical treatment of tissue
US1983669A (en) 1933-04-19 1934-12-11 Gen Electric X Ray Corp Electrode
US2056377A (en) 1933-08-16 1936-10-06 Wappler Frederick Charles Electrodic instrument
US2050904A (en) 1934-11-26 1936-08-11 Trice Spencer Talley Electric hemostat or cautery
US2224464A (en) 1936-09-03 1940-12-10 Firm Georg Wolf G M B H Thoracoscope
US2275167A (en) 1939-04-26 1942-03-03 Bierman William Electrosurgical instrument
US2888928A (en) 1957-04-15 1959-06-02 Seiger Harry Wright Coagulating surgical instrument
US3163165A (en) 1960-09-12 1964-12-29 Islkawa Humio Uterotube-closing instrument
US3152590A (en) 1961-04-27 1964-10-13 Zurdo Manuel Rodriguez Instrument for the depilation of superfluous hair
US3460539A (en) 1967-03-10 1969-08-12 James E Anhalt Sr Cautery tip
US3595239A (en) 1969-04-04 1971-07-27 Roy A Petersen Catheter with electrical cutting means
US3768482A (en) 1972-10-10 1973-10-30 R Shaw Surgical cutting instrument having electrically heated cutting edge
US3821510A (en) * 1973-02-22 1974-06-28 H Muncheryan Hand held laser instrumentation device
US3828780A (en) 1973-03-26 1974-08-13 Valleylab Inc Combined electrocoagulator-suction instrument
DE2324415C2 (en) 1973-05-15 1975-06-05 Aesculap-Werke Ag Vormals Jetter & Scheerer, 7200 Tuttlingen Surgical suction device
DE2324658B2 (en) 1973-05-16 1977-06-30 Richard Wolf Gmbh, 7134 Knittlingen PROBE FOR COAGULATING BODY TISSUE
CA1018419A (en) 1973-07-04 1977-10-04 Gerald Turp Instrument for laparoscopic tubal cauterization
US3870047A (en) 1973-11-12 1975-03-11 Dentsply Res & Dev Electrosurgical device
US3920022A (en) 1974-04-19 1975-11-18 Macey A Pastor Surgical instrument
US3901242A (en) 1974-05-30 1975-08-26 Storz Endoskop Gmbh Electric surgical instrument
US3987795A (en) 1974-08-28 1976-10-26 Valleylab, Inc. Electrosurgical devices having sesquipolar electrode structures incorporated therein
DE3412756A1 (en) 1984-04-05 1985-11-07 Bueß, Gerd, Dr.med., 5024 Pulheim ELECTRIC ARTHROSCOPY KNIFE
US4927420A (en) 1988-11-14 1990-05-22 Colorado Biomedical, Inc. Ultra-sharp tungsten needle for electrosurgical knife
US5027792A (en) * 1989-03-17 1991-07-02 Percutaneous Technologies, Inc. Endoscopic revision hip surgery device
DE4138115A1 (en) 1991-11-19 1993-05-27 Delma Elektro Med App MEDICAL HIGH FREQUENCY COAGULATION INSTRUMENT
US5697882A (en) * 1992-01-07 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US5334191A (en) 1992-05-21 1994-08-02 Dix Phillip Poppas Laser tissue welding control system
US5281218A (en) 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
WO1995022283A1 (en) 1992-10-26 1995-08-24 Ultrasonic Sensing & Monitoring Systems, Inc. Catheter using optical fibers to transmit laser and ultrasonic energy
US5342357A (en) * 1992-11-13 1994-08-30 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical cauterization system
US5428699A (en) * 1993-07-02 1995-06-27 Laserscope Probe having optical fiber for laterally directing laser beam
US5431649A (en) * 1993-08-27 1995-07-11 Medtronic, Inc. Method and apparatus for R-F ablation
JP3263275B2 (en) 1994-04-05 2002-03-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus
US5458596A (en) * 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5514130A (en) 1994-10-11 1996-05-07 Dorsal Med International RF apparatus for controlled depth ablation of soft tissue
US5612627A (en) 1994-12-01 1997-03-18 Advanced Micro Devices, Inc. Method for evaluating the effect of a barrier layer on electromigration for plug and non-plug interconnect systems
US5643255A (en) 1994-12-12 1997-07-01 Hicor, Inc. Steerable catheter with rotatable tip electrode and method of use
EP1006908A2 (en) 1997-02-12 2000-06-14 Oratec Interventions, Inc. Concave probe for arthroscopic surgery

Also Published As

Publication number Publication date
WO2001049196A1 (en) 2001-07-12
US6544260B1 (en) 2003-04-08
AU2292701A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
US6544260B1 (en) Method for treating tissue in arthroscopic environment using precooling and apparatus for same
US6068628A (en) Apparatus for treating chondromalacia
US5569242A (en) Method and apparatus for controlled contraction of soft tissue
US5785705A (en) RF method for controlled depth ablation of soft tissue
US5514130A (en) RF apparatus for controlled depth ablation of soft tissue
US6135999A (en) Concave probe for arthroscopic surgery
US5895386A (en) Bipolar coagulation apparatus and method for arthroscopy
US5954716A (en) Method for modifying the length of a ligament
US8864759B2 (en) Methods of treating the sacroiliac region of a patient's body
US20020058935A1 (en) Method for creating a virtual electrode for the ablation of tissue and for selected protection of tissue during an ablation
Shellock et al. Radiofrequency energy-induced heating of bovine articular cartilage using a bipolar radiofrequency electrode
US20030083652A1 (en) Method for treating tissue in arthroscopic environment
Foster et al. Arthroscopic delivery systems used for thermally induced shoulder capsulorraphy
Edwards III et al. Radiofrequency energy treatment effects on articular cartilage
Spahn et al. Treatment of chondral defects by hydro jet. Results of a preliminary scanning electron microscopic evaluation
Smith et al. Radiofrequency electrosurgery
Bhat et al. Electrosurgical injuries and their prevention in laparoscopic surgery
Isaacson New developments in radiofrequency technology for laparoscopic surgery
Cole et al. Radiofrequency energy for cartilage treatment
Gallizzi et al. Use of a low thermal injury dissection device reduces local tissue temperature change in a cadaveric model of anterior lumbar interbody fusion
Roux et al. Intracranial haemostasis with a neurosurgical CO 2-laser unit
Palmer Fundamentals of Energy Sources
Lu et al. Radiofrequency Thermal Energy Application on Articular Cartilage
Budny et al. ELECTROSURGICAL DEVICES: PREVENTION, CAUSES, AND TREATMENT

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/10-10/10; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP